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Gott hat niemals eine Krankheit entstehen lassen, für die Er nicht 
auch eine Arznei geschaffen hätte. 
Paracelsus 
 
 
 
 
God has never permitted a disease to exist for which he has not also 
created a treatment. 
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Abstract 
Acute pancreatitis is a common, debilitating condition characterised in its 
most severe form by organ necrosis as well as systemic inflammation, organ 
failure and death. The innate immune system, predominantly mediated 
through neutrophils, has been shown to contribute significantly to both 
pancreatic injury and respiratory failure: the leading cause of death in severe 
acute pancreatitis. Neutrophil extracellular traps, anti-microbial nuclear 
chromatin laced with proteases, are a recent discovery and contribute to the 
genesis of extracellular free radicals, microvascular thrombosis and abscess 
formation. 
Histones and histone fragments are critical active components of neutrophil 
extracellular traps. They are amongst the most widely conserved biochemical 
structures, are released as antimicrobial agents by a wide range of organisms 
and are uniquely toxic to cellular organisms. A central hypothesis for this work, 
is that the release of neutrophil extracellular traps, and their histone 
component in particular, is central to the way by which the innate immune 
response exacerbates acute pancreatitis. 
By using a 12-injection model of cerulein pancreatitis in mice depleted of 
specific innate immune cell subsets (Ly6G neutrophils, Ly6C monocytes and 
CCR2hi inflammatory monocytes), cytokine feedback mechanisms were 
identified and differential effects on pancreas and lung demonstrated by 
different cell types. In particular, CCR2hi pro-inflammatory monocytes 
appeared to contribute greatest to pancreatic injury, whereas Ly6Ghi 
neutrophils contributed most to lung injury. 
Using selective simultaneous measurement of portal, systemic venous and 
arterial blood, the liver was identified as the predominant source of circulating 
histones in acute pancreatitis, although hepatic immune cells are likely 
responsible for this signal amplification, similar to that seen with cytokines. 
Systemic injection of FITC-labelled histones demonstrated concentration 
within the pancreas only in concomitant pancreatitis. In (acinar) cellular 
isolates, histones led to dose-dependent necrosis by disrupting the 
plasmalemma. This in turn led to calcium currents across the membrane, 
which were not necessary to achieve cytotoxicity. 
By developing novel methodologies of measuring perfusion on a whole-organ 
level in mouse pancreas, an overall reduction in pancreatic perfusion is 
observed in cerulein AP, with patches of ischaemia resulting in focal necrosis 
on the same time-scale as maximal histone release. Pre-treatment with NETosis 
inhibitors reduced pancreatic injury, but histone detoxification as treatment 
(3-hours after induction of acute pancreatitis) was not effective. 
These results indicate modulation of innate immune mechanisms may allow 
future therapies to be targeted selectively at different phases of acute 
pancreatitis, to control extra-pancreatic effects and organ failure 
independently from pancreatic injury. Significant challenges remain to deliver 
therapies to a poorly perfused pancreas.  
Acknowledgements 
Peter Szatmary  February 2019 4 
Acknowledgements 
This body of work was made possible through the support and funding from 
the Royal College of Surgeons of England, the NIHR Liverpool Pancreas 
Biomedical Research Unit and the University of Liverpool’s North West Cancer 
Research Centre’s Research Development Fund, as well as a Royal Liverpool 
and Broadgreen University Hospitals NHS Trust Research Fellowship. 
I would like to thank my supervisors for their wisdom, support and 
encouragement. Specifically, I thank Professor Robert Sutton for allowing me 
great academic freedom to develop my own academic interests and 
direction while keeping me firmly on course, Professor Alexei Tepikin for 
accepting me into the ‘Blue Block’ family,  providing me with insight, 
guidance and state of the art technology, and Dr David Criddle for always 
having an open door and listening to my latest crazy endeavour before 
helping to make it more practicable. 
To Drs Wei Huang and Ting Ting Liu, with whom I have developed a close 
personal and professional friendship I say诶常感谢你, for keeping me busy, for 
strategic advice and for help with Western blots. 
To all of the members of the PBRU and Blue Block family who have helped me 
get this far: I am eternally grateful. Becky Taylor, I would still be trying to figure 
out how to get through the door without you; Diane Latawiec, your help 
getting equipment to work, finding samples and much more will not be 
forgotten; Jane Armstrong, thank you for showing me how to do things 
properly and apologies for the ‘mountains’; Muhammed Awais, thank you for 
your help and instruction on one of the most powerful and expensive 
instruments of the PBRU and to Svetlana Voronina and Mischa Chvanov for 
showing me how to apply these skills to probe sub-cellular processes; Emily 
Wen I thoroughly enjoyed our work together and hope you are well settled 
with your new family across the pond. 
Most sincerely I thank my wife Kathryn, for putting up with my long days as well 
as supporting me financially and emotionally during one of the formative 
periods of my life. 
Declaration of Academic Honesty 
Peter Szatmary  February 2019 5 
Declaration of Academic Honesty 
 
I hereby confirm that: 
- I have read and understood the University of Liverpool’s PGR Policy on 
Plagiarism and Dishonest Use of Data (Appendix 4 of the PGR Code of 
Practice, accessed Nov 2018). 
- I have acted honestly, ethically and professionally in conduct leading to 
assessment for the programme of study. 
- I have not copied material from another source, nor committed plagiarism 
nor fabricated, falsified or embellished data when completing this body of 
work. 
- I have not copied material from another source, nor colluded with any 
other student in the preparation and production of this material. 
- If an allegation of suspected academic malpractice is made, I give 
permission to the University of Liverpool to use source-matching software 
to ensure that the submitted material is all my own work. 
  
Contents 
Peter Szatmary  February 2019 6 
Contents 
ABSTRACT 3 
ACKNOWLEDGEMENTS 4 
DECLARATION OF ACADEMIC HONESTY 5 
CONTENTS 6 
ABBREVIATIONS 13 
LIST OF FIGURES 17 
1 INTRODUCTION 27 
1.1 ACUTE PANCREATITIS 27 
1.1.1 DISEASE BURDEN 27 
1.1.2 PATHOPHYSIOLOGY 28 
1.1.3 CHALLENGES INVESTIGATING HUMAN AP 29 
1.1.4 INFLAMMATION LINKS PANCREATIC NECROSIS TO ORGAN FAILURE 31 
1.1.5 THERAPEUTIC STRATEGIES 32 
1.2 NEUTROPHIL EXTRACELLULAR TRAPS 34 
1.2.1 COMPOSITION 34 
1.2.2 RELEASE MECHANISMS 34 
1.3 HISTONES 37 
1.3.1 BIOCHEMISTRY 37 
Contents 
Peter Szatmary  February 2019 7 
1.3.2 EXTRACELLULAR HISTONES IN DISEASE 38 
1.3.3 HISTONE-MEDIATED CELL INJURY 39 
1.3.4 IMMUNOTHROMBOSIS 40 
1.4 AIMS AND HYPOTHESES 42 
2 COMMON MATERIALS AND METHODS 45 
2.1 HUMAN TISSUE EXPERIMENTS 45 
2.2 EXPERIMENTAL ACUTE PANCREATITIS 45 
2.3 IN VITRO EXPERIMENTS 47 
2.4 REAGENTS 49 
2.5 SAMPLE PROCESSING 49 
2.5.1 BIOCHEMISTRY 49 
2.5.2 MYELOPEROXIDASE ACTIVITY 50 
2.5.3 TRYPSIN ACTIVITY 50 
2.5.4 HISTONE QUANTIFICATION 51 
2.5.5 HISTOPATHOLOGY 51 
2.5.6 DATA COLLECTION AND ANALYSIS 52 
3 THE INFLAMMATORY SEQUENCE IN ACUTE PANCREATITIS 53 
3.1 VISUAL ABSTRACT 53 
Contents 
Peter Szatmary  February 2019 8 
3.2 BACKGROUND 54 
3.3 SPECIFIC METHODS 56 
3.3.1 BLOOD AND TISSUE SAMPLING 56 
3.3.2 REAGENTS 56 
3.3.3 LEUKOCYTE PHENOTYPING 57 
3.3.4 CYTOKINE MEASUREMENT 57 
3.3.5 LEUKOCYTE DEPLETION 58 
3.4 CHEMOKINES ATTRACT MYELOID CELLS TO THE INFLAMED PANCREAS WHILE THE LIVER AMPLIFIES 
SYSTEMIC CYTOKINE SIGNALS 61 
3.5 INFLAMMATORY MONOCYTES AND NEUTROPHILS ARE RECRUITED TO THE PANCREAS AND DAMPEN 
FURTHER CHEMOKINE RELEASE 65 
3.6 MONOCYTES HAVE A GREATER ROLE IN PANCREATIC INJURY, WHEREAS NEUTROPHILS MAKE A 
GREATER CONTRIBUTION TO LUNG INJURY. 70 
3.7 DISCUSSION 73 
3.8 SUMMARY 75 
4 EXTRACELLULAR HISTONES CONTRIBUTE TO DISEASE SEVERITY IN ACUTE PANCREATITIS 77 
4.1 VISUAL ABSTRACT 77 
4.2 BACKGROUND 78 
4.3 SPECIFIC METHODS 79 
Contents 
Peter Szatmary  February 2019 9 
4.3.1 HUMAN SAMPLES 79 
4.3.2 IN VIVO EXPERIMENTS 79 
4.3.3 REAGENTS 80 
4.4 CIRCULATING NUCLEOSOME LEVELS CORRELATE WITH DISEASE SEVERITY IN HUMAN ACUTE 
PANCREATITIS 80 
4.5 THE LIVER IS THE PRIMARY SOURCE OF CIRCULATING HISTONES IN CERULEIN PANCREATITIS 83 
4.6 SYSTEMICALLY ADMINISTERED HISTONES EXACERBATE PANCREATIC INJURY IN MILD OEDEMATOUS 
EXPERIMENTAL PANCREATITIS 86 
4.7 SYSTEMICALLY ADMINISTERED HISTONES CONCENTRATE WITHIN AN INFLAMED PANCREAS 88 
4.8 DISCUSSION 90 
4.9 SUMMARY 92 
5 HISTONES ARE TOXIC TO PANCREATIC ACINAR CELLS 94 
5.1 VISUAL ABSTRACT 94 
5.2 BACKGROUND 95 
5.3 SPECIFIC METHODS 97 
5.3.1 EXPERIMENTAL ANIMALS 97 
5.3.2 CELLULAR CA2+ MEASUREMENTS 97 
5.3.3 REAGENTS 97 
5.4 HISTONES INDUCE PANCREATIC ACINAR CELL DEATH IN A TIME AND DOSE-DEPENDENT MANNER 98 
Contents 
Peter Szatmary  February 2019 10 
5.5 THE HISTONE-ACINAR CELL MEMBRANE INTERACTION IS MEDIATED BY CHARGE 102 
5.6 HISTONES INCREASE CALCIUM CONDUCTANCE ACROSS ACINAR CELL MEMBRANES 104 
5.7 PANCREATIC ACINAR CELL MEMBRANE INTEGRITY IS DISRUPTED BY EXTRACELLULAR HISTONES IN A 
CALCIUM-INDEPENDENT MANNER 107 
5.8 DISCUSSION 110 
5.9 SUMMARY 112 
6 PANCREATIC MICRO-PERFUSION IS IMPAIRED DURING ACUTE PANCREATITIS 113 
6.1 VISUAL ABSTRACT 113 
6.2 BACKGROUND 114 
6.3 SPECIFIC METHODS 117 
6.3.1 IN VIVO/IN SITU PERFUSION 117 
6.3.2 REAGENTS 122 
6.4 TOTAL PANCREATIC BLOOD FLOW IS REDUCED IN EXPERIMENTAL ACUTE PANCREATITIS 122 
6.5 CERULEIN-INDUCED SEVERE PANCREATITIS RESULTS IN PATCHY ORGAN PERFUSION AND NECROSIS125 
6.6 DISCUSSION 128 
6.7 SUMMARY 130 
7 HISTONES AND NETOSIS AS THERAPEUTIC TARGET IN ACUTE PANCREATITIS 131 
7.1 VISUAL ABSTRACT 131 
Contents 
Peter Szatmary  February 2019 11 
7.2 BACKGROUND 132 
7.3 SPECIFIC METHODS 133 
7.3.1 EXPERIMENTAL MODELS 133 
7.3.2 REAGENTS 133 
7.4 HEPARINS PROTECT PANCREATIC ACINAR CELLS FROM HISTONE-INDUCED INJURY 134 
7.5 THE EFFECT OF SYSTEMIC HEPARIN ADMINISTRATION DEPENDS ON THE TYPE OF HEPARIN USED 136 
7.6 HEPARINS INHIBIT THE DEGRADATION OF HISTONE H3 IN MOUSE PLASMA 140 
7.7 THE EFFECT OF SYSTEMIC HEPARIN ADMINISTRATION IS DEPENDENT ON THE SEVERITY OF 
EXPERIMENTAL ACUTE PANCREATITIS 142 
7.8 PRE-TREATMENT WITH AN INHIBITOR OF NETOSIS AMELIORATES EXPERIMENTAL ACUTE 
PANCREATITIS 144 
7.9 DISCUSSION 147 
7.10 SUMMARY 150 
8 OVERVIEW 151 
8.1 RESPONSE TO PANCREATIC INSULT 152 
8.2 SYSTEMIC MEDIATORS OF PANCREATIC INFLAMMATORY SYNDROME 154 
8.3 CHALLENGES IN THE TREATMENT OF ACUTE PANCREATITIS 156 
8.3.1 DISEASE ACTIVITY INDEX 158 
8.3.2 IMMUNOTHROMBOSIS AND DRUG DELIVERY 159 
 Peter Szatmary  February 2019 12 
8.3.3 PORTAL SEPSIS AND THE LIVER AS GATEKEEPER OF SYSTEMIC INFLAMMATION 162 
8.4 CONCLUDING REMARKS 163 
9 REFERENCES 164 
10 APPENDIX – PUBLICATIONS ARISING FROM THIS THESIS 193 
 
 
  
Abbreviations 
A 
ALT - Alanine Aminotransferase ................................................................................................................. 48, 81, 88 
AP - Acute Pancreatitis ................................................................................................... 26, 29, 42, 88, 89, 123, 126 
ATP - Adenosine Triphosphate .............................................................................................................................. 31 
B 
BSA - Bovine Serum Albumin ............................................................................................................................ 28, 50 
C 
CBA – Cytokine Bead Assay ................................................................................................................................... 60 
CCL2 - C-C Ligand 2 ........................................................................................................................................... 60, 72 
CCR2 - C-C Chemokine Receptor 2 ................................................................................................................... 72, 74 
CFTR - Cystic Fibrosis Transmembrane Regulator ................................................................................................. 28 
CG - Cathepsin G .................................................................................................................................................... 35 
CRP - C Reactive Protein ....................................................................................................................... 76, 79, 88, 94 
CXCL-1 - C-X-C Ligand 1 .................................................................................................................................... 60, 72 
CXCR2 - C-C Chemokine Receptor 2 ...................................................................................................................... 35 
D 
DAMP - Damage Associated Molecular Pattern ............................................... 28, 31, 33, 53, 73, 89, 126, 146, 159 
DAMPs - damage associated molecular patterns ................................................................................................ 154 
DIC - Disseminated Intravascular Coagulopathy ................................................................................................... 40 
DNA - Deoxyribonucleic Acid .................................................................................................... 36, 37, 38, 39, 40, 93 
E 
EDTA - Ethylenediaminetetraacetic Acid .................................................................................................... 49, 55, 56 
ELISA - Enzyme Linked Immunosorbent Assay ................................................................................................. 77, 78 
ERCP - Endoscopic Retrograde Cholangiopancreatography .................................................................................. 27 
Abbreviations 
Peter Szatmary  February 2019 14 
F 
FASP - Factor VII-Activating Protease .................................................................................................................. 138 
FITC - Fluorescein Isothianate ................................................................................................ 48, 78, 86, 87, 90, 100 
Fluo4-AM – 4-(6-Acetoxymethoxy-2,7-difluoro-3-oxo-9-xanthenyl)-4’-methyl-2,2’-(ethelynedioxy)dianiline-
N,N,N’,N’-tetraacetic acid tetrakis(acetoxymethyl) ester .............................................................................. 102 
Fura-2-AM - Fura 2 Pentakis(Acetoxymethyl) Ester ............................................................................................ 102 
H 
HDAP - Histone Derived Antimicrobial Peptide ..................................................................................................... 38 
HMGB1 - High Mobility Group Box Protein 1 ......................................................................................... 31, 146, 157 
I 
ICAM-1 - Intercellular Adhesion Molecule 1 ......................................................................................................... 53 
IFNg - Interferon gamma ....................................................................................................................................... 60 
IL-1b - Interleukin 1 beta .......................................................................................................................... 60, 72, 157 
IL-6 – Interleukin 6 ................................................................................................................................................. 60 
IL-8 - Interleukin 8 ................................................................................................................................................. 33 
IQR - Interquartile Range ....................................................................................................................................... 51 
K 
KC - Keratinocyte Chemoattractant ...................................................................................................................... 72 
L 
LMWH - Low Molecular Weight Heparin ..................................................................................................... 131, 134 
LPS - Lipopolysaccharide .................................................................................................................. 33, 35, 154, 160 
M 
Mac-1 - Macrophage-1 Antigen ............................................................................................................................ 34 
MCP-1 - Monocyte Chemoattractant Protein 1 .................................................................................................... 72 
MPO - Myeloperoxidase ..................................................................................................... 34, 36, 46, 53, 70, 84, 87 
Abbreviations 
Peter Szatmary  February 2019 15 
MPTP - Mitochondrial Permeability Transition Pore ........................................................................................... 113 
N 
NADPHO - Nicotinamide Adenine Dinucleotide Phosphate Oxidase ......................................................... 33, 34, 53 
PHOX - Phagocyte Oxidase ............................................................................................................................... 34 
NE - Neutrophil Elastase ................................................................................................................................... 35, 36 
NET - Neutrophil Extracellular Trap .............................................................. 32, 33, 34, 35, 36, 40, 54, 89, 127, 128 
NETing .............................................................................................................................................................. 41 
NETosis ............................................................................................ 34, 37, 39, 40, 42, 54, 81, 93, 142, 143, 147 
NHS - National Health Service .......................................................................................................................... 46, 49 
NIHR - National Institute for Health Research .................................................................................................. 77, 78 
NLR - NOD-like Receptors ...................................................................................................................................... 31 
NOD - Nucleotide-binding Oligomerisation Domain ............................................................................................. 31 
O 
OAG - 1-oleoyl-2-acetyl-sn-glycerol ....................................................................................................................... 34 
ODS - 2-0, 3-0 Desulfated Heparin ............................................................................... 132, 134, 136, 138, 140, 146 
P 
PAC – Pancreatic acinar cell .................................................................................................................................. 31 
PAD4 - Protein Arginine Deiminase 4 ............................................................................................. 35, 142, 143, 147 
PBS - Phosphate Buffered Saline .................................................................................................................... 46, 120 
PI - Propidium Iodide ................................................................................................................ 48, 96, 100, 102, 132 
PKC - Protein Kinase C ........................................................................................................................................... 34 
PKCz - Protein Kinase C Zeta ............................................................................................................................ 34 
PMA - Phorbol 12-myristate 13-acetate ........................................................................................................... 33, 34 
PR3 - Proteinase 3 ................................................................................................................................................. 35 
R 
RAGE - Receptor for Advanced Glycation End-products ....................................................................................... 31 
ROC - Receiver Operator Characteristic ........................................................................................................... 77, 79 
 Peter Szatmary  February 2019 16 
ROS - Reactive Oxygen Species .......................................................................................................... 34, 36, 54, 113 
S 
SDS-PAGE - Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis ............................................................ 50 
SEM - Standard Error of the Mean ........................................................................................................................ 51 
SIRS - Systemic Inflammatory Response Syndrome ............................................................................................ 156 
T 
TLR - Toll-like Receptor ..................................................................................................................................... 31, 34 
TNF - Tumour Necrosis Factor .......................................................................................................................... 60, 72 
TNFa - Tumour Necrosis Factor alpha ............................................................................................................ 156 
TRITC - Tetramethylrhodamine Isothianate ................................................................................................. 116, 120 
U 
UFH - Unfractionated Heparin ........................................................................................ 50, 132, 134, 138, 145, 146 
V 
vWF - von Willebrand Factor ................................................................................................................................. 41 
 
  
List of Figures 
Peter Szatmary  February 2019 17 
List of Figures 
Figure 3-1 Gating strategies in the identification of monocyte, macrophage 
and neutrophil populations in murine whole blood, pancreas and spleen. 
The initial whole-cell population (left) selects the leukocyte population 
gating on CD45 positivity, whereas monocytes (Ly6C+/CD11b+; top right) 
and neutrophils (Ly6G+/CD11b+; bottom right) are selected from the 
leukocyte population. Cell viabilities >95% for all cell types. .................... 59 
Figure 3-2 Standard curves of mean cytokine bead array fluorescence 
generated from recombinant protein standards with associated linear or 
non-linear regression curves used for extrapolation of cytokine 
concentrations. R2 consistently > 0.99 for all measured cytokines. .......... 60 
Figure 3-3 Chemokines CCL2 (MCP-1) and CXCL-1 (KC) measured in blood 
from portal vein, thoracic vena cava and left ventricle from mice with 
acute pancreatitis induced by 12 hourly cerulein injections or saline 
controls. Samples were taken one and 13 hours after the final cerulein 
injection. Comparisons were made by 2-way ANOVA and multiple t-tests 
using Benjamini, Kriegler, Yekutieli false-discovery method. * denotes 
p<0.05 between anatomical locations and timepoints; n ³ 6. ................. 63 
Figure 3-4 Cytokines IL-1b and TNF measured in blood from portal vein, 
thoracic vena cava and left ventricle from mice with acute pancreatitis 
induced by 12 hourly cerulein injections or saline controls. Samples were 
taken one and 13 hours after the final cerulein injection. IL-6 
measurements were taken from portal and systemic venous blood only. 
Comparisons were made by 2-way ANOVA and multiple t-tests using 
List of Figures 
Peter Szatmary  February 2019 18 
Benjamini, Kriegler, Yekutieli false-discovery method. * denotes p<0.05 
between anatomical locations and timepoints; n ³ 6. ............................. 64 
Figure 3-5 Monocytes (Ly6C+) and Neutrophils (Ly6G+) as a proportion of 
leukocytes (CD45+) or total viable cells measured with multi-colour flow 
cytometry. Data points are from whole blood, pancreas (collagenase 
digestion) and spleen (homogenate) from CD-1 Swiss mice 12 and 24h 
following induction of acute pancreatitis with 12 hourly injections of 
cerulein (50µg/kg, i.p.). Comparisons are made to saline control by 
ANOVA, where red colour of the data set indicates p<0.05; n ³ 5. ......... 67 
Figure 3-6 Effect of neutrophil or monocyte depletion on the other cell-type in 
blood. Blood samples were taken from tail vein of CD-1 Swiss mice prior to 
induction of acute pancreatitis, and from cardiac puncture 24h following 
12 hourly injections of cerulein (50µg/kg, i.p.). Cell numbers refer to event 
numbers (Ly6G – neutrophils, Ly6C – monocytes) measured by multi-
colour flow cytometry as a proportion of total leukocyte (CD45+) 
numbers. All comparisons are to the control group by ANOVA, where * 
denotes p<0.05, ** p<0.01, *** p<0.001 and **** p<0.000; n ³ 6. ............... 68 
Figure 3-7 Plasma cytokine levels measured by cytokine bead assay from CD-
1 Swiss mice 24 hours after induction of acute pancreatitis with 12 hourly 
injections of cerulein (50µg/kg, i.p.) and following depletion of  classical 
monocytes (Ly6C), inflammatory monocytes (CCR2) and neutrophils 
(Ly6G) with a single injection of the relevant monoclonal antibody 12h 
prior to induction of pancreatitis. All comparisons are to the control group 
by ANOVA, where * denotes p<0.05, ** p<0.01, *** p<0.001 and **** 
p<0.0001; n ≥ 6. .............................................................................................. 69 
List of Figures 
Peter Szatmary  February 2019 19 
Figure 3-8 Biochemical parameters (pancreas and lung MPO activity, 
pancreatic trypsin activity and plasma amylase) from organ 
homogenates and plasma of CD-1 Swiss mice after induction of acute 
pancreatitis with 12 hourly injections of cerulein (50µg/kg, i.p.) and 
depletion of classical monocytes (Ly6C), inflammatory monocytes 
(CCR2) and neutrophils (Ly6G) using specific monoclonal antibodies. All 
comparisons are to the control group by ANOVA, where * denotes p<0.05, 
** p<0.01, *** p<0.001 and **** p<0.0001; n ³ 6. .......................................... 71 
Figure 3-9 Histopathological scores from pancreata of CD-1 Swiss mice pre-
treated with depletion of classical monocytes (Ly6C), inflammatory 
monocytes (CCR2) and neutrophils (Ly6G) using specific monoclonal 
antibodies. All comparisons are to the control group by ANOVA, where * 
denotes p<0.05, ** p<0.01, *** p<0.001 and **** p<0.0001; n ³ 6. ............. 72 
Figure 4-1 A) Levels of circulating nucleosomes relative to each other in 
plasma from patients with mild, moderate or severe acute pancreatitis 
according to the revised Atlanta classification of Acute Pancreatitis. B) 
Receiver operator characteristic of circulating nucleosomes on 
admission, as well as CRP on admission and at 48 hours in predicting 
severe disease at any time during admission. C) Quantitative Western blot 
of circulating histones in patients with mild, moderate or severe acute 
pancreatitis. Comparisons between two groups were done using the 
Mann-Whitney U test, where * denotes p<0.05, ** p<0.01, *** p<0.001 and 
**** p<0.0001; n = 50. ...................................................................................... 82 
Figure 4-2 A) Western blot of histones in murine plasma after induction of acute 
pancreatitis with 12 i.p. injections of 50 µg/kg cerulein, sampled from 
List of Figures 
Peter Szatmary  February 2019 20 
portal vein, vena cava and left ventricle in the same animal. Parallel lines 
link bands from the same animal. B) Relative density of histone H3 bands 
from different sample locations. All comparisons are to each other group 
by ANOVA, where * denotes p<0.05; n = 6. ................................................ 84 
Figure 4-3 A) Plasma ALT levels in mice with acute pancreatitis induced by 12x 
i.p. injections of 50 µg/kg cerulein and saline controls. B) Histopathological 
slide of liver (x20 magnification) stained with Haematoxilin and Eosin, 
denoting perfusion zones I-III and direction of blood flow (yellow arrow). 
Comparisons are made using Student’s t-test, where * denotes p<0.05; n 
≥ 6. .................................................................................................................. 85 
Figure 4-4 A) Serum amylase concentration, B) pancreatic and C) lung 
myeloperoxidase activity and D) blinded histopathological assessment of 
the pancreas (oedema, infiltration and necrosis) in experimental acute 
pancreatitis induced by 4x hourly i.p. injections of 50 µg/kg cerulein or 
saline controls, both with and without co-administration of 20 mg/kg i.v. 
calf thymus histones. E) Representative micrograph of histologic 
appearance of pancreata of treated animals. All comparisons by 
ANOVA, where * denotes a difference of p<0.05 to control and # denotes 
a difference of p<0.05 to cerulein; n ³ 6. .................................................... 87 
Figure 4-5 A) Epifluorescent image of murine organs following i.v. injection of 
FITC-labelled histones in cerulein AP or saline controls; inset is close-up 
view of pancreas and spleen. Fluorescence intensity in pancreata of B) 
cerulein or C) saline treated animals with or without administration of FITC-
labelled histones. Fluorescence intensity of all extracted organs (except 
List of Figures 
Peter Szatmary  February 2019 21 
bladder) in D) cerulein AP or E) saline controls. All comparisons are by 
ANOVA (parametric data) or Kruskall-Wallace test (non-parametric). * 
denotes p<0.05, and ** p<0.01; n ≥ 5. ........................................................ 89 
Figure 5-1 A) Propidium iodide-related fluorescence in freshly isolated murine 
pancreatic acinar cells following administration of different doses of calf-
thymus histones over time (mean +/- SEM), as measured on a POLARStar 
multiwall plate reader. Maximum propidium iodide-related fluorescence 
in response to increasing doses of B) calf-thymus, or C) human 
recombinant histones. All comparisons are by ANOVA. * denotes p<0.05, 
** p<0.01 and *** p<0.001. Experiments performed in triplicate; n ≥ 4 
experimental repeats. .................................................................................. 100 
Figure 5-2 Confocal micrograph of freshly isolated murine pancreatic acinar 
cells 60 minutes following treatment with different concentrations of calf-
thymus histones. Fluorescence images represent signals due to Hoechst 
3342 (blue) membrane permeable nuclear dye and Propidium Iodide 
(red), membrane impermeable nuclear dye. .......................................... 101 
Figure 5-3 A) Representative confocal micrograph of a cluster of murine 
pancreatic acinar cells over time following treatment with FITC-labelled 
histones; FITC (green), PI (red). Maximal recorded PI-related fluorescence 
in freshly isolated murine pancreatic acinar cells after administration of 
different doses of calf-thymus histones following B) poly-acetylation or 
C&D) in the presence of negatively charged macromolecules. All 
comparisons are by ANOVA. * denotes p<0.05, ** p<0.01 and *** p<0.001. 
Experiments performed in triplicate; n ³ 4 experimental repeats. .......... 103 
List of Figures 
Peter Szatmary  February 2019 22 
Figure 5-4 Freshly isolated murine pancreatic acinar cell cluster loaded with 
calcium sensitive dye A) fluo4-AM or B) the ratiometric calcium-sensitive 
dye fura-2 AM, following treatment with calf-thymus histones. F1/F0 signal 
over time. ....................................................................................................... 106 
Figure 5-5 Representative trace of fura 2-related signal (340nm solid line, 
380nm dashed line) in murine pancreatic acinar cell treated with 
100µg/ml calf-thymus histones in the A) presence and B) absence of 
extracellular calcium (1.2mM and 0mM). C) Mean (+/- SEM) fura 2 – 
related signal following histone treatment in all observed cells. D) Maximal 
% PI uptake in histone-treated acinar cells in normal, calcium free and 
calcium excess containing buffers. Comparisons are by ANOVA, 
observations made in triplicate with n ≥ 4 experimental repeats. ........ 109 
Figure 6-1 Arterial perfusion set-up. Diagram of liver, pancreas, aorta, and 
vena cava, detailing the set-up for arterial pancreatic perfusion. The 
black arrow indicates placement of the perfusion cannula. The black 
parallel lines indicate Bulldog clamps. Picture insets (top to bottom): 
Bulldog clamp on supra-hepatic vena cava; in situ pancreas following 
perfusion with Methylene Blue; abdominal aorta (lefted by forcepts) next 
to abdominal vena cava. ........................................................................... 120 
Figure 6-2 Portal venous perfusion set-up. Diagram of liver, pancreas, aorta, 
portal vein and vena cava detailing the set-up for portal venous 
pancreatic perfusion. The black arrow indicates placement of the 
perfusion cannula. The black parallel lines indicate occlusive sutures. 
Picture insets (top to bottom): perfusion cannula sutured in place within 
List of Figures 
Peter Szatmary  February 2019 23 
portal vein; in situ pancreas and proximal small bowel following perfusion 
with Methylene Blue. .................................................................................... 121 
Figure 6-3 A) Murine pancreatic blood flow estimated from pancreatic 
fluorescence following injection of 15µm fluorescenct microspheres via 
the carotid artery of CD1 Swiss mice under terminal anaesthesia. and 
concomitant fluorescence measurement of a known volume of femoral 
arterial blood collected over 60 seconds. B) Comparison of fluorescence 
in left and right kidneys as indication of even mixing of fluorescent 
particles. Solid oblique line indicates equivalent fluorescence; dotted line 
indicates 20% deviation from equivalence. Comparisons were made by 
Student’s t-test, with * denoting p<0.05 and ** p<0.01; n ≥ 12. ............. 124 
Figure 6-4 Fluorescence measurement of mouse pancreata perfused with 
fluorescent microspheres in cerulein-pancreatitis or saline controls. A) 
epifluorescence chamber image of microsphere-perfused murine 
pancreata suspended in agarose gel. B) whole-organ fluorescence 
following homogenisation and dye extraction from perfused pancreata. 
C) H&E-stained micrographs of pancreata from two distinct cerulein-
treated mice at 100x and 400x magnification, demonstrating areas of 
significant necrosis (blue arrow) adjacent to near-normal tissue (yellow 
arrow) as well as thrombosis of a peripheral arteriole causing near total 
lobular necrosis (black arrow). Comparisons are by Student’s t-test, with * 
denoting p<0.05 and ** p<0.01; n ≥ 8. ...................................................... 126 
Figure 6-5 MRI images of pancreata from mice treated with 12x hourly 
injections of 50µg/kg caerulen or saline controls. A&B) 3D reconstruction 
List of Figures 
Peter Szatmary  February 2019 24 
and volumetry of specimen, where yellow/red indicates areas of high 
perfusion in A, and B is colour-coded by organ (green = duodenum, 
yellow = pancreas and red = spleen). C) T1-weighted images with Gd(III)-
based contrast medium and T2-weighted images with FeO nanoparticles 
as contrast agent. Insets demonstrate vascular discontinuity and 
irregularity (red) and areas of hypoperfusion (blue). ............................... 127 
Figure 7-1 Maximal recorded PI uptake in freshly isolated murine pancreatic 
acinar cells following administration of different doses of calf-thymus 
histones in the presence of two different types of heparin: unfractionated 
heparin and 2-0, 3-0-desulfated (low anticoagulant) heparin. 
Comparisons by ANOVA, where * denotes p<0.05, ** p<0.01, *** p<0.001 
compared to control and # denotes p<0.05 compared to both control 
and other treatment group. Observations were made in triplicate with n 
≥ 4 experimental repeats. .......................................................................... 135 
Figure 7-2 Plasma amylase and IL-6 concentration, pancreatic trypsin and 
pancreatic and lung myeloperoxidase activity as well as blinded 
histopathological assessment of the pancreas (oedema, infiltration and 
necrosis) in experimental acute pancreatitis induced by 12x hourly i.p. 
injections of 50µg/kg cerulein or saline controls. Therapeutic groups all 
cerulein pancreatitis with three different types of heparin (UFH – 5000 
IU/kg, ODS heparin – 25 mg/kg and LMWH – Tinzaparin 25 mg/kg). All 
comparisons by ANOVA, where * denotes a difference of p<0.05 to 
cerulein; n ≥ 6. ............................................................................................. 137 
List of Figures 
Peter Szatmary  February 2019 25 
Figure 7-3 Plasma amylase, IL-6, histone H3 and ALT concentration, pancreatic 
and lung myeloperoxidase activity as well as pancreatic trypsin activity in 
experimental acute pancreatitis induced by 12x hourly i.p. injections of 
50µg/kg cerulein or saline controls. Therapeutic groups all cerulein 
pancreatitis with low (10 mg/kg) and high (25 mg/kg) doses of the non-
anticoagulant ODS heparin. All comparisons by ANOVA, where * denotes 
a difference of p<0.05 to control and # denotes a difference of p<0.05 to 
cerulein; n ≥ 6. ............................................................................................. 139 
Figure 7-4 Western blot of recombinant histone H3 incubated at room 
temperature in pooled plasma (C57Bl6/J) and treated with 
unfractionated (UFH) or non-anticoagulant ODS heparin; n = 3 
experimental repeats. .................................................................................. 141 
Figure 7-5 Plasma amylase concentration, pancreatic trypsin and pancreatic 
and lung myeloperoxidase activity as well as blinded histopathological 
assessment of the pancreas (oedema, infiltration and necrosis) in 
experimental acute pancreatitis induced by 4x hourly i.p. injections of 
50µg/kg cerulein or saline controls. Therapeutic group cerulein 
pancreatitis with non-anticoagulant ODS heparin (25 mg/kg). All 
comparisons by ANOVA; n ≥ 6. ................................................................. 143 
Figure 7-6 Plasma amylase and histone H3 concentrations, pancreatic trypsin 
and pancreatic and lung myeloperoxidase activity as well as blinded 
histopathological assessment of the pancreas (oedema, infiltration and 
necrosis) in experimental acute pancreatitis induced by 12x hourly i.p. 
injections of 50µg/kg cerulein or saline controls. Therapeutic groups all 
List of Figures 
Peter Szatmary  February 2019 26 
cerulein pancreatitis, pre-treated with the PAD-4 inhibitors GSK-484 (1 or 
10 mg/kg) and Cl-amidine (40 mg/kg). All comparisons by ANOVA, where 
* denotes a difference of p<0.05 to saline and # denotes a difference of 
p<0.05 to cerulein; n ≥ 6. ............................................................................ 146 
  
Introduction 
Peter Szatmary  February 2019 27 
1 Introduction 
1.1 Acute pancreatitis 
1.1.1 Disease burden 
Acute Pancreatitis (AP) is an acute inflammatory disease of the exocrine 
pancreas, for which a disease-modifying, specific therapy is yet to be found. 
Despite several hundred randomised controlled trials the mainstay of therapy 
remains supportive, with modest improvements in mortality resulting from 
improvements in care pathways and critical care medicine (Godi, Eross et al. 
2018; Mandalia, Wamsteker et al. 2018).  
AP is diagnosed through a combination of clinical evaluation, imaging and 
biochemical analysis (IAP/APA Working Group 2013). It has an incidence 
ranging from 4.6 to 100 cases per 100,000 population per year in Europe 
(Roberts, Morrison-Rees et al. 2017) and occurs at similar frequencies in other 
Westernised nations (Yadav and Lowenfels 2013; Pendharkar, Mathew et al. 
2017). It is one of the commonest specific gastrointestinal disorder leading to 
hospitalisation and annual costs escalating from $2.5 billion to $9.2 billion (1997 
versus 2012) in the US alone (Peery, Dellon et al. 2012; Wadhwa, Patwardhan 
et al. 2017). Although the initial injury is confined to the pancreas, a subset of 
patients develop systemic disease contributing to significant morbidity and 
mortality (Banks, Bollen et al. 2013). 
This work sets out to better understand the inflammatory processes that form 
the link between pancreatic injury and organ failure, ultimately the cause of 
mortality in patients with severe AP. It further aims to describe mechanisms 
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that can be targeted on a clinically-relevant time-scale and form the basis of 
the development of therapy that can alter the course of the disease. 
1.1.2 Pathophysiology 
The first reported death from necrotizing acute pancreatitis was in 1760, by 
the Italian anatomist Giovanni Battista Morgagni and the first description of 
an experimental model of acute pancreatitis by Claude Bernard through 
retrograde infusion of bile into the pancreatic duct followed in the early 19th 
century (Keminger 2001). The first documented case of human AP of known 
aetiology by Eugene Opie in 1901 was as a result of a gallstone (Lerch, 
Weidenbach et al. 1994). While research into the pathophysiology of acute 
pancreatitis continued thereafter, only the advances in cell biology, 
immunology and imaging of the late 20th century allowed detailed 
understanding of the complex interactions that result in pancreatic 
inflammation, necrosis and organ dysfunction. 
Gallstones and alcohol are now the commonest aetiological factor for acute 
pancreatitis in Europe (Parniczky, Kui et al. 2016; Roberts, Morrison-Rees et al. 
2017), with hyperlipidaemia, idiopathic and post-ERCP pancreatitis 
accounting for nearly all remaining cases. Associated factors including 
obesity (Ikeura, Kato et al. 2017; Yoon, Choi et al. 2017) and smoking (Kim, 
Chung et al. 2017; Stigliano, Belisario et al. 2017) exacerbate the severity of 
each episode of acute pancreatitis and increase the likelihood of recurrent 
episodes. On a cellular level, injury to pancreatic acinar cells leads to influx 
and overload of intra-cellular calcium (Voronina, Collier et al. 2015; Wen, 
Voronina et al. 2015), which in turn promotes mitochondrial dysfunction and 
cell death (Mukherjee, Mareninova et al. 2016). Activation of zymogens 
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occurs within the pancreatic parenchyma and propagates (or initiates, in the 
case of hereditary pancreatitis) cellular injury (Van Acker, Weiss et al. 2007; 
Athwal, Huang et al. 2014). Activated lipase causes lipolysis of visceral fat, 
providing a putative mechanism of how obesity exacerbates disease severity 
(Patel, Trivedi et al. 2015). Alcohol and cigarette smoke further contribute to 
disease severity by inhibiting CFTR (Hegyi, Wilschanski et al. 2016), thereby 
limiting chlorine currents, ductal secretion and clearance of activated 
proteases (Kadiyala, Lee et al. 2013). Injured acinar cells release a cascade 
of chemokines and cytokines, while necrotic cells release DAMPs which lead 
to the recruitment of immune cells and initiation of a local and systemic 
inflammatory response (Gukovskaya, Gukovsky et al. 2017). 
1.1.3 Challenges investigating human AP 
Due to the anatomical constraints of a gland situated deep within the 
peritoneal cavity, surrounded by major vasculature (Tsuchitani, Sato et al. 
2016) and the likelihood that many disease-relevant changes occur prior to 
presentation to hospital (Kambhampati, Park et al. 2014; Afghani, Pandol et 
al. 2015), use of experimental models is critical in AP. Significant differences in 
digestive systems of vertebrates, however, mean mammalian models are 
indispensable, allowing meaningful comparison to human disease. Even 
within mammals, however, there are significant anatomical differences 
between the primate pancreas and the more commonly utilised 
experimental animals – rodents (Tsuchitani, Sato et al. 2016). Because of their 
low maintenance costs and availability of powerful genetic tools, rodents 
have become the mainstay for pancreatitis research. Nevertheless, there are 
further differences between baseline metabolic and immune functions 
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between rodents and human that lead to documented differences in 
response to other systemic inflammatory diseases such as sepsis (Iskander, 
Osuchowski et al. 2013; Fink 2014) or trauma (Frink, Andruszkow et al. 2011). 
To investigate organ-specific effects such as organ necrosis or inflammatory 
infiltration, or systemic responses such as organ failure, in vivo models of AP 
are used. The commonest of these aim to replicate the common aetiologies 
of AP in humans, biliary obstruction by gallstones and chronic alcohol excess 
(Frossard, Steer et al. 2008) and include invasive techniques to obstruct bile 
duct drainage or inject bile acids into the pancreatic duct (Perides, van Acker 
et al. 2010; Wan, Huang et al. 2012) or injection of ethanol and fatty acid 
metabolites (Criddle, Raraty et al. 2004). While these models replicate human 
disease in principle, they have the disadvantage of necessitating anaesthesia 
and surgery (bile acid model) or injection of high concentrations of ethanol 
or solvent which in turn lead to local and systemic effects of the injection 
vehicle. The commonest in vivo model of experimental acute pancreatitis is 
hyperstimulation by infusion or repeated injections of the cholecystokinin 
analogue cerulein (Saluja, Saito et al. 1985). While this model is not directly 
representative of human disease, it has the advantage of producing dose-
sensitive pancreatic inflammation without mortality, is cheap and 
reproducible. 
Investigating pathophysiological events on a cellular level can often be done 
in in vitro and ex vivo preparations of isolated pancreatic acinar cells 
(Williams, Korc et al. 1978; Orabi, Muili et al. 2013), acinar cell lobules (Flowe, 
Welling et al. 1994) or slices (Huang, Gaisano et al. 2011) and isolated, 
perfused pancreas (Otsuki, Sakamoto et al. 1979; Reaven, Curry et al. 1983). 
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Pancreatic acinar cells rapidly lose their exocrine phenotype and trans-
differentiate into ductal-type cells in culture (Hall and Lemoine 1992; De 
Waele, Wauters et al. 2014), necessitating fresh harvest of cells for each 
experiment. However, acinar cells from any species (including human) can 
be interrogated in this manner. 
1.1.4 Inflammation links pancreatic necrosis to organ failure 
At the first international consensus meeting on acute pancreatitis in Atlanta in 
1992, pancreatic necrosis was deemed sufficient to categorize acute 
pancreatitis as severe (Bradley 1993). However, a realisation that necrosis in 
the absence of organ failure probably did not by itself contribute to a 
significant increase in mortality (Ashley, Perez et al. 2001) led to a revision of 
the original Atlanta Classification (Banks, Bollen et al. 2013) which 
downgraded the significance of pancreatic necrosis in the absence of organ 
failure and led to the development of a rival classification system, which 
eliminated the inclusion of pancreatic necrosis as a determinant of severity 
entirely (Dellinger, Forsmark et al. 2012). 
Organ failure is rarely a global phenomenon in acute pancreatitis. The lung is 
generally the first or only organ to fail (Szatmary, IAP Presentation 2015) and is 
an independent predictor or mortality (Skouras, Hayes et al. 2014; Parniczky, 
Kui et al. 2016). Lung injury in AP can be direct, through circulating toxins and 
activated pancreatic proteases bypassing the liver through the thoracic duct 
in mesenteric lymph (Mittal, Phillips et al. 2009), or indirect through the injurious 
effects of innate immune cells. 
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Pancreatic acinar cell (PAC) injury induces synthesis and release of pro-
inflammatory cytokines (Gukovskaya, Gukovsky et al. 1997; Szatmary and 
Gukovsky 2016) and PAC death releases pro-inflammatory DAMPs (including 
histones, HMGB1 and ATP) (Kang, Lotze et al. 2014). Extracellular nuclear 
proteins can be measured as early as four hours after induction of 
experimental acute pancreatitis (Ou, Cheng et al. 2015; Schneider, 
Jabrailova et al. 2015) and act via common immune sensors and initiators 
including toll-like receptors (TLRs, nucleotide binding domain (NOD)-like 
receptors (NLRs) and receptor for advanced glycation end-products (RAGE) 
to initiate sterile inflammation (Chen and Nunez 2010). 
This initial response generates an early cellular response consisting of glandular 
infiltration with neutrophils and monocytes, which appear to exacerbate injury 
(Frossard, Saluja et al. 1999; Gukovskaya, Vaquero et al. 2002), act together 
with peritoneal macrophages and hepatic Kupffer cells to amplify pro-
inflammatory cytokines in experimental acute pancreatitis (Gloor, Todd et al. 
1998; Gloor, Blinman et al. 2000; Lundberg, Eubanks et al. 2000), and are at 
least in part responsive for early onset organ failure seen in some acute 
pancreatitis patients (Oiva, Mustonen et al. 2010; Oiva, Mustonen et al. 2013). 
1.1.5 Therapeutic Strategies 
Very few therapeutic trials in human acute pancreatitis have shown promise 
and even fewer ultimately successful, underlining the difficulties faced by 
researchers hoping to translate animal studies into human treatments. A prime 
example of this are the lexipafant trials – a series of randomised controlled 
trials of a platelet activating factor inhibitor (Kingsnorth, Galloway et al. 1995; 
McKay, Curran et al. 1997; Wyncoll and Beale 1998; Johnson, Kingsnorth et al. 
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2001), which were powered on crude endpoints such as mortality and 
reduction in proportion of complications and included patients up to 72 hours 
after onset of the disease and often with established organ failure. 
Nevertheless, they demonstrated a tendency to a reduction in severity of 
organ failure. 
Inhibitors of pancreatic proteases have been developed and are used in 
clinical practice, predominantly in Japan, given intra-venously or as 
continuous regional arterial infusion alone and in conjunction with antibiotics 
with mixed effects. Despite promise in some observational studies, larger 
cohort studies and meta-analyses have shown no benefit (Hamada, 
Yasunaga et al. 2013; Horibe, Egi et al. 2015; Horibe, Sasaki et al. 2017), and 
use is not recommended in the latest version of the Japanese guidelines for 
the management of acute pancreatitis (Yokoe, Takada et al. 2015). 
Experimentally, gabexate mesilate and nafamostat mesilate (two sereine 
protease inhibitors in clinical use) infusions improved pancreatic blood flow 
and increased capillary density in rats with severe acute pancreatitis (Keck, 
Friebe et al. 2005). This effect, however, has only been demonstrated in 
concomitant- or pre-treatment. 
A recently discovered innate immune mechanism - neutrophil extracellular 
traps (NETs) - potentially links these trials. Their release is stimulated through the 
interaction with activated platelets and regulated by neutrophil elastase: 
another serine protease. The next sections describe the biology of NETs and 
the role of histones, one of their principle structural components. 
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1.2 Neutrophil extracellular traps 
1.2.1 Composition 
Neutrophil extracellular traps, or NETs, were first described in 2004 as fragile 
fibres released by neutrophils in response to IL-8, LPS or PMA (Brinkmann, 
Reichard et al. 2004). NETs are composed of DNA strands, linked by histones 
and laced with neutrophil elastase, cathepsin G and myeloperoxidase. The 
release process is dependent on NADPHO and results in nuclear chromatin 
decondensation, translocation of granular proteins to the nuclear material, 
disintegration of the nuclear envelope and release of formed NETs (Fuchs, 
Abed et al. 2007). 
1.2.2 Release Mechanisms 
A large number of signals have been shown to be able to induce NET, 
including bacteria (Berends, Horswill et al. 2010; Juneau, Pang et al. 2011; 
Young, Malcolm et al. 2011), viruses (Narasaraju, Yang et al. 2011; Saitoh, 
Komano et al. 2012), yeasts (Urban, Reichard et al. 2006; Bruns, Kniemeyer et 
al. 2010), parasites (Baker, Imade et al. 2008; Abi Abdallah, Lin et al. 2012), 
organic crystals (Mitroulis, Kambas et al. 2011; Schauer, Janko et al. 2014), non-
organic matter (Bartneck, Keul et al. 2010; Jhunjhunwala, Aresta-DaSilva et al. 
2015), cytokines (Keshari, Jyoti et al. 2012; Rossaint, Herter et al. 2014) and 
cellular breakdown products including DAMPs (Tadie, Bae et al. 2013; Huang, 
Tohme et al. 2015). To detect such a varied set of stimuli, there is overlap and 
convergence of receptor pathways. This may explain some variability in early 
genetic knock-out studies when defining which receptor is critical in 
mediation NET release. It would seem molecular pattern-related NET release is 
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mediated predominantly through toll-like receptors (TLR) 2, 4 and 9 (Clark, Ma 
et al. 2007; Allam, Scherbaum et al. 2012; Semeraro, Ammollo et al. 2014; 
Huang, Tohme et al. 2015), immune complex-related NET release is mediated 
via Fc receptors and MAC-1 (Behnen, Leschczyk et al. 2014) and larger 
pathogens or inorganic matter lead to NETosis through sheer size. The inability 
to phagocytose large particles within a given time appears to drive 
neutrophils to auto-digest and release NETs in a process dependent on dectin-
1 (Branzk, Lubojemska et al. 2014). 
Following signal detection, there are three critical steps leading to NET release: 
phagocyte oxidase (PHOX/NADPHO) activation, nuclear protease 
translocation and histone de-imination. 
Involvement of PHOX/NADPHO is illustrated by patients with chronic 
granulomatous disease, an inherited defect in PHOX activity, who are unable 
to produce NETs when stimulated with phorbol 12-myristate 13-acetate (PMA) 
and present with recurrent and/or persistent infections(36). PHOX/HADPHO is 
activated by protein kinase C (PKC). Experimentally, pan-activation of PKC 
isoforms using PMA or the di-acyl glycerol analogue 1-oleoyl-2-acetyl-sn-
glycerol (OAG) effectively stimulates NETosis (Gray, Lucas et al. 2013). 
Inhibition of NADPHO or myeloperoxidase (MPO) effectively inhibits NETosis 
stimulated by PMA, whereas inhibition of mitochondrial respiration or 
superoxide dysmutase does not (Kirchner, Moller et al. 2012). Specific inhibition 
of PKC isoform b inhibits both reactive oxygen species (ROS) production by 
PHOX and NETosis, however there are conflicting reports on whether PKCz is 
also able to inhibit NETosis (Gray, Lucas et al. 2013; Neeli and Radic 2013). 
There are increasing reports of NADPHO-independent NETosis, such as via the 
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src kinase family in response to chemokine receptors (CXCR2) activation 
(Marcos, Zhou et al. 2010) or via unspecified pathways following high-dose 
uric-acid stimulation (Arai, Nishinaka et al. 2014). 
Histone de-imination by peptidyl-arginine transferase 4 (PAD4) is an essential 
step towards NET release (Neeli and Radic 2012). PAD4 targets methyl-
arginine residues, reducing methylation and increasing citrullination on 
H4Arg3 and H3Arg2, 8 and 17 residues in HL-60 cells (Wang, Li et al. 2009) over 
a time scale of 15 minutes to 2 hours, in a manner independent of caspase 
activity (Neeli, Khan et al. 2008). These same post-translational modifications 
are amongst the most immunogenic histone modifications seen in serum from 
patients with systemic lupus erythematosus (Liu, Tangsombatvisit et al. 2012), 
and levels of circulating nucleosomes and citrullinated histone H3 correlate 
with disease severity in acute inflammatory conditions including sepsis (Hirose, 
Hamaguchi et al. 2014), trauma (Abrams, Zhang et al. 2013) and pancreatitis 
(Ou, Cheng et al. 2015). Genetic deletion of PAD4 leads to an inability of 
neutrophils to release NETs in response to calcium ionophore treatment or LPS 
(Martinod, Demers et al. 2013) and pharmacological inhibition of PAD4 inhibits 
NET formation in murine and human neutrophils (Lewis, Liddle et al. 2015). 
Overexpression of PAD4, on the other hand, has been shown to cause histone 
hypercitrullination, nuclear de-condensation and release of NET like structures 
in an osteosarcoma cell line (Leshner, Wang et al. 2012). 
Nuclear translocation of granular proteases is the final step towards NET 
release. Neutrophil azurophilic granules contain neutrophil elastase (NE), 
proteinase 3 (PR3) and cathepsin G (CG), however only NE is translocated to 
the nucleus and neither inhibition of PR3 nor CG can prevent this translocation 
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(Papayannopoulos, Metzler et al. 2010). Furthermore, the process is not 
mediated by fusion of granules with the nucleus, but rather NE dissociates from 
the granular membrane in a ROS-dependent manner before degrading 
cytosolic actin, arresting actin dynamics and translocating across the nuclear 
membrane using specific translocation mechanisms (Metzler, Goosmann et 
al. 2014). Binding of nucleic acid by proteases initiates a process of 
degradation of nuclear binding proteins(Thomas, Whangbo et al. 2014) and 
controlled integration of MPO into the forming NET. Nuclear NE leads to early 
degradation of linker histone H1, followed by core histone H4 which coincides 
with nuclear chromatin de-condensation (Papayannopoulos, Metzler et al. 
2010). Histone H3 appears to be resistant to degradation in intact nuclei, but 
not in purified form, suggesting one of the purposes of post-translational 
modification is to render histone H3 resistant to NE related degradation. 
1.3 Histones 
1.3.1 Biochemistry 
Histones are positively charged nuclear proteins which help to package DNA 
into nucleosomes common to all eukaryotic cells. They were first described by 
Albrecht Kossel as histidine-rich peptones (his-tones) derived from avian red 
blood cell nuclei in 1884 (Kossel 1884); he was awarded the Nobel Prize in 
Physiology and Medicine for this and other work on the nucleus of cells in 1910. 
The structures and sequences of histones are highly conserved across all 
eukaryotic species (McGhee and Felsenfeld 1980; Talbert and Henikoff 2010), 
and allow them to act as nuclear chaperone proteins, interacting with nucleic 
acids due to their highly net-positive charge (Park and Luger 2008) from 
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arginine and lysine residues (Sugano, Olson et al. 1972; Yeoman, Olson et al. 
1972). Each nucleosome particle consists of 147 base pairs of DNA, wrapped 
in 1.7 turns around a protein octamer of core histones (H2A, H2B, H3 and H4), 
further compacted by linker histones H1 and/or H5 (Luger, Mader et al. 1997). 
Numerous post-translational modifications of histones have been identified to 
date, including acetylation, methylation, phosphorylation, ubiquitylation, 
sumoylation, ADP ribosylation, deamination and proline isomerisation 
(Kouzarides 2007). In normal cell function, these alter the nature of the histone-
DNA interaction and allow transcription to occur. 
More recently, controlled histone degradation has been described in 
neutrophils leading to chromatin de-condensation and release of genomic 
DNA laced with granular proteins as neutrophil extracellular traps (NETs) 
(Brinkmann 2004; Papayannopoulos, Metzler et al. 2010). These meshwork-like 
structures promote intravascular thrombosis (Fuchs, Brill et al. 2010), limit 
spread of micro-organisms, encourage cancer metastasis (Cools-Lartigue, 
Spicer et al. 2013) and cause direct injury to adjacent cells (Allam, Kumar et 
al. 2014). 
1.3.2 Extracellular Histones in Disease 
Two types of disease process are associated with a significant increase in 
circulating histones: systemic infections and ischaemic processes. In sepsis in 
particular, extracellular histones have been identified as viable biomarkers 
and anti-histone strategies are being trialled as potential therapies (Xu, Huang 
et al. 2015). The seemingly lacking connection between infective and 
ischaemic/thrombotic diseases can be reconciled by the introduction of the 
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concept of immune-thrombosis. Histones, released as part of NETs, induce 
microvascular thrombosis to limit the spread of micro-organisms (McDonald, 
Urrutia et al. 2012), but the undifferentiated response in sterile inflammation 
leads to exacerbation of the initial injury. This phenomenon can be seen in a 
range of human diseases, including stroke (Geiger, Holdenrieder et al. 2007; 
De Meyer, Suidan et al. 2012), heart attack (Savchenko, Borissoff et al. 2014), 
acute lung injury (Saffarzadeh, Juenemann et al. 2012) and ischaemic renal 
injury (Rosin and Okusa 2012). 
1.3.3 Histone-mediated Cell Injury 
A wide variety of organisms release histones and their degradation products 
as microbicidal agents in the form of histone-derived antimicrobial peptides 
(HDAP), with their activity documented in vitro (Tagai, Morita et al. 2011; 
Wang, Chen et al. 2011) as well as in animal (Drab, Kracmerova et al. 2014) 
and human (Kim, Cho et al. 2002) disease. 
Exogenous histones appear to affect cells (including microbes) in one of two 
ways: permeabilization of membranes, or DNA-binding and disruption of 
transcription. In human disease, cellular injury by histones has been described 
in lung (Bosmann, Grailer et al. 2013), heart (Kalbitz, Grailer et al. 2015; 
Alhamdi, Zi et al. 2016), liver (Xu, Zhang et al. 2009; Huang, Chen et al. 2013), 
kidney (Allam, Scherbaum et al. 2012) and vascular endothelium 
(Saffarzadeh, Juenemann et al. 2012). Histone concentrations below 10 µg/ml 
seem to have a signalling function and can induce calcium transients in cells 
(Gamberucci, Fulceri et al. 1998). Concentrations greater than 10 µg/ml (or 20 
µg/ml in the presence of serum) induce cell death by an uncertain 
mechanism, probably involving the formation of non-selective cationic pores 
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in membranes (Kleine, Lewis et al. 1997; Lete, Sot et al. 2014). Bactericidal 
properties of histone fragments are dependent on the ability to form 
amphipathic alpha-helices – potentially membrane spanning domains – 
however no such structural analyses have been performed on mammalian 
cells to date (Koo, Kim et al. 2008). 
The interaction of histones with cell membranes is heavily reliant on charge. 
Positively charged histones preferentially bind anionic phospholipids such as 
cardiolipin or phosphatidylserine, but not zwitterionic phospholipids like 
phosphatidylcholine (Pereira, Marco et al. 1994). Furthermore, adding 
negative change (e.g.: a phosphate head group as in phosphatidylinositol-
bis-phosphate) increases the binding capacity of histones as measured by 
calorimetry (Lete, Sot et al. 2014). Histones have also been shown to expose 
phosphatidyl serine on the surface of red blood cells in a dose-dependent 
manner (Semeraro, Ammollo et al. 2014), however it is unclear whether this 
resulted from altered flippase kinetics or via induction of apoptosis pathways. 
Negatively charged acute-phase proteins (such as C-reactive protein) 
(Abrams, Zhang et al. 2013), DNA (Lete, Sot et al. 2014), polysaccharides 
(Fuchs, Bhandari et al. 2011) or synthetic macromolecules (Gamberucci, 
Fulceri et al. 1998) compete with membrane phospholipid-binding and 
prevent histone integration and toxicity. 
1.3.4 Immunothrombosis 
Recent data suggests that histones, both in isolation and as components of 
NETs, can influence the coagulation cascade to initiate venous thrombosis 
(Fuchs, Brill et al. 2010; Brill, Fuchs et al. 2012; von Bruhl, Stark et al. 2012). 
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Furthermore, circulating nucleosomes are associated with and independent 
prognostic markers of disseminated intravascular coagulopathy (DIC) (Kim, 
Lee et al. 2015), leading to some countries, notably Japan, to actively 
promote the use of anticoagulants as histone detoxification agents in the 
treatment of DIC (Iba, Gando et al. 2014). Positive correlation between 
histone levels and coagulopathy can also be seen in trauma patients 
(Kutcher, Xu et al. 2012) and patients with sepsis (Wildhagen, Wiewel et al. 
2015). 
Histones act synergistically to produce a profound pro-coagulant state. 
Histones are able to induce platelet aggregation, factor V/Va expression and 
prothrombinase activity, leading to thrombin activation independent of the 
intrinsic coagulation pathway (Semeraro, Ammollo et al. 2011). Histones also 
inhibit thrombomodulin and protein C activation (Ammollo, Semeraro et al. 
2011), an effect most pronounced with histones H3 and H4, thus reducing a 
natural inhibitor system. Furthermore, histone H4 binding promotes thrombin 
auto-activation, probably by fixing the prothrombin molecule in a 
conformational state conducive to proteolytic attack (Barranco-Medina, 
Pozzi et al. 2013). The only exception is liker histone H1, which has been shown 
to reduce thrombin activation and prolong clotting times (Kheiri, Fasy et al. 
1996); this mechanism is likely insignificant in acute inflammation, as histone 
H1 is amongst the first nuclear proteins to be degraded in the process of 
NETosis. 
The presence of DNA in NETs also allows activation of the intrinsic coagulation 
pathway, demonstrated by NET-enhanced thrombin generation in platelet-
poor plasma, reduced by factor XII/factor XI depletion or DNAse 
Introduction 
Peter Szatmary  February 2019 42 
treatment(Gould, Vu et al. 2014). DNAse treatment in platelet-rich plasma 
further increases thrombin generation, indicating differential effects of 
histones and NETs in different microenvironments. The addition of histones and 
DNA also increases fibrin fibre thickness, clot stability and delayed clot lysis 
(Longstaff, Varju et al. 2013) as well as reducing anti-thrombin-mediated 
thrombin inactivation and plasmin activity (Varju, Longstaff et al. 2015). In in 
vivo systems, the interplay between von Willebrand factor (vWF), platelets and 
neutrophils anchor neutrophils to otherwise healthy vessel walls and permit 
NETing neutrophils to initiate clot formation (Kolaczkowska, Jenne et al. 2015; 
Slaba, Wang et al. 2015), with propagation presumably aided by the 
mechanisms described above. Deficiencies in degradation of vWF produce 
clinical microangiopathies (e.g. thrombotic thrombocytopaenic purpura), 
the severity of which is also closely correlated with circulating NET components 
in humans (Fuchs, Kremer Hovinga et al. 2012). 
1.4 Aims and hypotheses 
To investigate the role of innate immunity in acute pancreatitis and the 
resulting systemic inflammatory syndrome, the following hypotheses and aims 
were generated. 
1. Pancreatic injury results in recruitment of innate immune cells, resulting in 
an exacerbation of injury. Therefore: 
a. depletion of specific pro-inflammatory cell types (monocytes 
and/or neutrophils) will ameliorate pancreatic injury. 
b. there is a negative feedback loop by which inflammation is 
contained and total destruction of the exocrine pancreas 
avoided. 
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Using antibody-mediated depletion of specific myeloid subsets in 
experimental acute pancreatitis and measuring panels of inflammatory 
cytokines, these hypotheses have been addressed in work described in 
chapter 3. 
2. Histones and histone fragments interact directly with pancreatic acinar 
cells to increase membrane permeability and cell death. Histones are 
generated within the pancreas through necrosis and/or active release by 
infiltrating immune cells, exacerbating injury to surrounding tissues. From 
this follows that: 
a. there is a measurable increase in calcium permeability of acinar 
cells in response to histone treatment. 
b. histone treatment of freshly isolated pancreas results in cellular 
necrosis that is in proportion to exposure. 
c. histone concentrations are highest in the portal circulation. 
d. histone concentrations correlate with disease severity. 
The aim here has been to address the above hypotheses in a manner 
relevant to clinical pancreatitis, yet consistent with the principles of the 
three Rs. Therefore, human serum levels have been measured to correlate 
histone levels with disease severity in chapter 4. Portal histone levels have 
been measured in an experimental model, also described in chapter 4, 
and effects on membrane integrity evaluated in cellular isolates in chapter 
5. 
3. Acute pancreatitis features small and medium-vessel thromboses, resulting 
in impaired microvascular perfusion in severe AP. Preventing NETosis or 
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detoxification of histones with heparin ameliorates AP on a cellular and 
whole-organ level. 
Small-medium vessel perfusion studies in mouse are difficult to achieve. 
Nevertheless, this study aims to develop novel assays to evaluate the 
perfusion of small and medium sized blood vessels on a whole-organ level, 
allowing visualisation of patchy perfusion, as described in chapter 6. These 
methods have then been used to evaluate potential therapies in the 
treatment of acute pancreatitis as described in chapter 7.  
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2 Common Materials and Methods 
2.1 Human tissue experiments 
Blood Samples 
Patients with acute pancreatitis included in the National Institute of Health 
Research Liverpool Pancreas Biomedical Research Unit Acute Pancreatitis 
Biobank were selected at random and plasma samples obtained as 
approved by the regional ethics committee (REC 10/H1308/31). All adult (18-
99 years of age) patients attending the Royal Liverpool University Hospital with 
a diagnosis of acute pancreatitis of any aetiology (amylase >450 IU, typical 
pain and/or pancreatic inflammation on cross-sectional imaging) were 
eligible for inclusion to the biobank. Patients who were unable to consent (e.g. 
unconscious), had a history of recurrent acute or chronic pancreatitis or a 
history of pancreatic surgery or malignancy were excluded. Samples were 
collected prospectively within 24 hours of admission from consenting patients 
who had presented within 72 hours of onset of pain, together with clinical data 
that allowed severity stratification according to the 2012 Revised Atlanta 
Classification (Banks, Bollen et al. 2013). All samples were processed within 30 
minutes of blood sampling and stored at 80 °C. Collection, processing, 
storage, monitoring and usage of samples followed pre-defined standard 
operating procedures and Good Clinical Practice. 
2.2 Experimental acute pancreatitis 
Experimental Animals 
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All animal studies were ethically reviewed and conducted as per the UK 
Animals (Scientific Procedures) Act 1986 under a project license approved by 
the UK Home Office (PPL 70/8109). Male C57BL/6J mice (age 8-10 weeks; 20-
25 g) and Male CD1 Swiss mice (age 10-12 weeks; 30-35 g) were purchased 
from Charles River UK Ltd (Margate, Kent, UK), housed in a pathogen-free unit 
with 12 h light-dark cycles and had free access to standard lab chow and 
water. 
In vivo models 
Mild oedematous acute pancreatitis was induced by 4 hourly (Ou, Cheng et 
al. 2015) and necrotising acute pancreatitis by 12 hourly (Huang, Cane et al. 
2015; Ou, Cheng et al. 2015) intraperitoneal injections of cerulein (50 µg/kg). 
Analgesia was provided by subcutaneous injection of buprenorphine (1 
mg/kg) together with the first cerulein injection, and again with the 12th 
injection in animals culled later than the 12-hour time point. All animals were 
visually monitored throughout the procedure and removed from experiments 
if unexpectedly unwell. At the end of experiments, animals were culled by a 
method regulated by schedule 1 of the UK Animals (Scientific Procedures) Act 
1986 at a time point stated in the chapter specific methods, but in general 
either one hour after the last cerulein injection (ie either 4 or 12 hours after 
induction of acute pancreatitis), or 24 hours after induction of acute 
pancreatitis. 
Pre-treatments were given as stated in the text, but at least one hour before 
the first cerulein injection. Treatments were given as stated in the chapter 
specific methods, but in general together with the third cerulein injection. 
Common Materials and Methods 
Peter Szatmary  February 2019 47 
Sample extraction from in vivo models 
Details of sample collection and timings can be found in the chapter-specific 
methods. Where blood sampling was undertaken before induction of acute 
pancreatitis, this was from tail vein in temporarily immobilised animals 
according to standard procedures of the University of Liverpool Biomedical 
Sciences Unit. At the end of an experiment, blood was extracted using EDTA-
coated syringes and sampling bottles via cardiac puncture. Approximately 
600-800 µl blood was extracted per mouse. Blood was immediately spun using 
a table-top microcentrifuge at 1500 rpm for 10 minutes and plasma snap 
frozen on dry ice. Pancreas as well as both lungs (and other organs as detailed 
in specific methods) were extracted, washed in PBS and divided into three 
parts of similar volumes. Two pancreas segments were snap frozen on dry ice 
for MPO and trypsin activity analysis. The third segment was fixed in 4% formalin 
for at least 24 hours. The left lung was injected intra-bronchially with 4% 
formalin and fixed for at least 24 hours. The right lung was washed in PBS and 
snap frozen in dry ice for MPO activity assessment. Formalin-fixed specimens 
were submitted to The Royal Liverpool University Hospital Department of 
Histopathology for Paraffin embedding and 5 µm sectioning to NHS standards. 
Frozen samples were stored at -80 °C until further analysis. 
2.3 In vitro experiments 
Pancreatic acinar cell isolation 
Murine pancreatic acinar cells were freshly isolated (Raraty, Ward et al. 2000; 
Gerasimenko, Gryshchenko et al. 2013; Huang, Booth et al. 2014) and cell 
death assays performed as previously prescribed, with minor alterations of 
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protocols (Zhang, Mizumoto et al. 1999; Huang, Cash et al. 2015). In brief, 
experimental animals were culled using an appropriate method regulated by 
schedule 1 of the UK Animals (Scientific Procedures) Act. All three lobes of the 
pancreas were surgically extracted from spleen to duodenum and washed in 
freshly made Na+-HEPES buffer (containing 140 mM NaCL; 4.7 mM KCl; 10 mM 
HEPES; 1 mM MgCl2; 10 mM glucose; 1.2 mM CaCl2; adjusted to pH 7.3), 
referred to as HEPES buffer from this point. The pancreas was then injected 
with collagenase solution (200 units/ml HEPES) and incubated for between 15 
and 20 minutes (depending on the batch of collagenase) in a shaking water 
bath at 37 °C in a 1.5 ml Eppendorf tube. Following incubation, the pancreas 
was washed in excess HEPES and shaken vigorously in a 15 ml Falcon tube. 
After one minute of sedimentation, the supernatant filtered through a 100 µm 
pore-size wet cell filter into a fresh 15 ml Falcon tube (cell suspension), and this 
cycle was repeated several times until the supernatant in the tube with the 
digested pancreatic tissue remained clear.  The cell suspension was spun at 
600 g for 60 seconds in a table top centrifuge, the pellet washed in HEPES 
buffer and spun again twice, before re-suspending the cell pellet in HEPES 
buffer (at about 106 cells/ml), ready for experimental use. 
Cell death assays 
For cell death assays, freshly isolated pancreatic acinar cells were suspended 
in HEPES in the presence of PI (2 µl) and seeded on a 96 well plate in a total 
volume of 200 µl per well. Signal was recorded every minute (Ex 540 nm/Em 
620 nm) for 150 minutes using a BMG POLARstar Omega Microplate Reader 
(Imgen Technologies, New York, USA). Histones (50, 100 or 200 µg/ml) or 
digitonin (600 µM) was added after 30 minutes of establishing a stable 
Common Materials and Methods 
Peter Szatmary  February 2019 49 
baseline. Percentage cell death in each experimental well was calculated as 
a proportion of maximum fluorescence in digitonin wells (Zhang, Mizumoto et 
al. 1999). Confocal images of isolated acinar cells were taken using a Zeiss 
LSM 510 or 710 (ZEISS Microscopy, Cambridge, UK) inverted confocal 
microscope with a 40x (air) or 63x (water) objective. Cells were seeded onto 
Poly-L-Lysine coated cover slips and placed in a perfusion chamber 
containing HEPES solution. Excitation lasers and emission spectra were 
selected to match fluorescent dyes used and minimise spectral 
overlap/background fluorescence. In general, FITC was excited using a 488 
nm laser, collecting signal between 505 nm and 530 nm and PI excited using 
a 543 nm laser, collecting signal between 620 nm and 700 nm. 
2.4 Reagents 
Digitonin was from Calbiochem (Manchester, UK). BCA protein assay was from 
Thermo (Rockford, USA). Anti-histone H3 antibody was from Abcam (Rabbit 
monoclonal, 1:100 dilution; Abcam, Cambridge, UK), Calf-thymus histones, 
propidium iodide (PI), poly-D-glutamic acid (PGA), cerulein, acetic 
anhydride, protease inhibitors, phosphate-buffered saline (PBS) and other 
chemicals were from Sigma-Aldrich (Gilliangham, UK) of highest quality 
available. HEPES, Tris and Phosphate buffers were made fresh either on the 
day (HEPES) or within 4 weeks of use.  
2.5 Sample processing 
2.5.1 Biochemistry 
For biochemical analysis of amylase, ALT and creatinine, plasma was diluted 
1:4 in PBS (20 µl for amylase, 50 µl for ALT and creatinine) and submitted for 
Common Materials and Methods 
Peter Szatmary  February 2019 50 
analysis to The Royal Liverpool University Hospital Department of Biochemistry 
for analysis to NHS standards. 
2.5.2 Myeloperoxidase activity 
Pancreatic and/or lung myeloperoxidase activity was determined as 
previously described (Dawra, Ku et al. 2008). Tissue samples were processed 
frozen. Samples were mechanically homogenised in phosphate buffer (100 
mM, pH 7.4) spiked with protease inhibitors, before subjecting samples to two 
(lung) or three (pancreas) cycles of ultracentrifugation (16,000 x g, 15 minutes) 
and three freeze-thaw cycles in low pH phosphate buffer (100 mM, pH 5.4) 
containing 0.5% hexadecyltrimethyl ammonium bromide and 10mM EDTA. 
Myeloperoxidase activity from the supernatant was measured in 3, 3’, 5, 5’-
tetramethylbenzidine solution by the addition of 0.01% H2O2 and recording the 
absorbance change at 655 nm over 3 minutes using a BMG POLARstar 
Omega Microplate Reader (Imgen Technologies, New York, USA). 
Enzyme activity was reported per mg of protein as measured using a standard 
BCA protein assay (Pierce BCA Protein Assay Kit, Thermo Fisher Scientific, UK) 
as per the manufacturer’s instructions. 
2.5.3 Trypsin activity 
Samples were processed frozen similarly to previously published protocols 
(Nathan, Romac et al. 2005). Pancreas segments were homogenized in MOPS 
buffer (5 mmol/l MOPS; 1 mmol/l MgSO4; 250 mmol/l sucrose; adjusted to pH 
6.5) on ice before centrifugation at 1500 g for 10 minutes at 4 °C. 10 µl 
supernatant was added to a 96 well plate containing 50 µM Boc-Gln-Ala-Arg-
MCA peptide substrate in 280 µl warmed Tris buffer (50 mmol/l Tris; 150 mmol/l 
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NaCl; 1 mmol/l CaCl2; 0.01% BSA; 37 °C), collecting fluorescence signal at 440 
nm with 380 nm excitation, once every minute for 6 minutes, using a BMG 
POLARstar Omega fluorescence microplate reader (Imgen Technologies, 
New York, USA). The rate of signal increase between 1 and 5 minutes was 
taken as a relative measure of trypsin activity and expressed as relative 
activity per mg protein as determined for each sample using a standard BCA 
protein assay (Pierce BCA Protein Assay Kit, Thermo Fisher Scientific, UK) as per 
the manufacturer’s instructions. 
2.5.4 Histone quantification 
Plasma samples were obtained as above in EDTA tubes spiked with 0.1% UFH. 
Histone quantification was undertaken as previously described (Ou, Cheng et 
al. 2015), either in a blinded manner by Tingting Liu (see acknowledgement 
section), or as standard Western blot. In brief, plasma was subjected to SDS-
PAGE using recombinant human histone H3 protein as standard and 
detected by Western blot (5% milk block for 1 hour, primary antibody 
incubation at 4 °C overnight, wash x3 with TBST, anti-rabbit IgG-HRP secondary 
antibody for 1 hour all except primary incubation at room temperature). 
2.5.5 Histopathology 
Histopathological slides were prepared and stained with Haematoxilin and 
Eosin by The Department of Histopathology at The Royal Liverpool University 
Hospital. Slide identifiers were covered, and histopathological scoring was 
performed on 10 random fields (x200 magnification) by two experienced, 
independent investigators blinded to experimental groups. Scores (0-4) were 
given for each of oedema, inflammatory cell infiltrate and acinar cell necrosis 
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(Kusske, Rongione et al. 1996; Xu, Zhou et al. 2007) in a modification from the 
commonly used 3 point score (Van Laethem, Robberecht et al. 1996). 
2.5.6 Data collection and analysis 
Data was collected, stored and analysed using Prism 7.0c for Mac OS X. Data 
are presented as mean (+/- SEM) for parametric, or median (+/- IQR) for non-
parametric data, and compared using Student’s t-test (2-group comparison, 
parametric), ANOVA (3+-group comparison, parametric) or Wilcoxon signed-
rank (2-group comparison, non-parametric) or Kruskal-Wallis (3+-group 
comparison, non-parametric) unless otherwise stated in the chapter specific 
methods. All graphical representations are generated using Prism 7.0c for Mac 
OS X, and all drawings were generated using Graphic for Mac v3.1. 
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3 The Inflammatory Sequence in Acute Pancreatitis 
3.1 Visual abstract 
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3.2 Background 
Acute pancreatitis is a disease with two distinct, yet interrelated components 
– pancreatic injury and sterile inflammation (Hoque, Malik et al. 2012; 
Habtezion 2015). Under physiological circumstances, neutrophils are absent in 
the pancreatic parenchyma (Sandoval, Gukovskaya et al. 1996). Acinar cell 
injury leads to the release of DAMPs and cytokines, which prime vascular 
endothelium to express adhesion molecules such as ICAM-1 and promotes 
recruitment of neutrophils and monocytes to the site of injury (Zaninovic, 
Gukovskaya et al. 2000; Habtezion and Algul 2016; Szatmary and Gukovsky 
2016). 
In human acute pancreatitis, a rapid rise of circulating neutrophils in relation 
to other leukocytes is associated with disease severity and organ failure 
(Zhang, Wu et al. 2016; Jeon and Park 2017) and MPO (Chooklin, Pereyaslov 
et al. 2009) and neutrophil elastase (Novovic, Andersen et al. 2013) activity 
correlates with disease severity. In experimental acute pancreatitis, neutrophil 
recruitment Is one of the earliest events in the disease happening within the 
first 2 hours following injury (Abdulla, Awla et al. 2011), peaking at 6 hours in a 
cerulein hyperstimulation model (Montecucco, Mach et al. 2014). Limiting this 
recruitment through genetic knock-out of ICAM-1 expression (Frossard, Saluja 
et al. 1999) or the neutrophil activating molecule NADPH Oxidase 
(Gukovskaya, Vaquero et al. 2002), inhibition of the CXCR2 chemokine 
receptor (Malla, Karrman Mardh et al. 2016) or by antibody-mediated 
depletion (Sandoval, Gukovskaya et al. 1996; Bhatia, Saluja et al. 1998; Pastor, 
Vonlaufen et al. 2006) improves biochemical and histopathological 
parameters of pancreas and lung injury. 
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Several mechanisms have been postulated, including activation of 
trypsinogen by neutrophil proteases (Abdulla, Awla et al. 2011; Awla, Abdulla 
et al. 2012; Tracy 2012), ROS-mediated injury (Montecucco, Mach et al. 2014) 
or NET-mediated tissue damage (Merza, Rahman et al. 2014; Korhonen, 
Dudeja et al. 2015). Inhibition of neutrophil elastase, which also effectively 
inhibits NETosis (Majewski, Majchrzak-Gorecka et al. 2016), has proved 
effective in preventing pancreatitis-associated lung and renal injury, but 
demonstrated only modest reductions in pancreatic injury (Wang, Tang et al. 
2012; Cao and Liu 2013; Wang, Tang et al. 2013). 
Some of the difference in the profound amelioration in pancreatic injury seen 
with neutrophil depletion versus functional inhibition might be explained by 
the methods used to achieve neutrophil depletion. Early studies used murine 
anti-neutrophil serum to achieve profound neutrophil depletion in rats 
(Sandoval, Gukovskaya et al. 1996; Bhatia, Saluja et al. 1998; Frossard, Saluja 
et al. 1999) and these all demonstrated significant improvement in pancreatic 
as well as lung injury. The traditional method of generation of anti-neutrophil 
serum results in polyclonal anti-serum, that likely depletes monocytes and 
platelets as well as neutrophils. Other studies used methotrexate (Fujimoto, 
Hosotani et al. 1997), anti-integrin (CD18) antibodies (Williams, Collins et al. 
1990; Inoue, Nakao et al. 1995), or anti-GR-1 antibodies (Abdulla, Awla et al. 
2011) to deplete neutrophils. These have effects other than neutrophil 
depletion, which are often not evident in the study methodologies. In 
particular, the GR-1 (but also CD18) depletion methods deplete pro-
inflammatory monocytes as well as neutrophils (Egan, Sukhumavasi et al. 
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2008). This work attempts to detail the differential contributions of neutrophils 
and monocytes to the pathogenesis of cerulein pancreatitis. 
3.3 Specific methods 
3.3.1 Blood and tissue sampling 
Blood for leukocyte phenotyping was collected fresh in EDTA bottles as per 
general methods. Splenocytes were generated by pressing freshly collected 
spleens through a 100 µm sterile cell filter, and isolated pancreatic acinar cells 
were generated by collagenase digestion as per the general methods but 
digesting for 20 minutes and filtering through a 75 µm sterile cell filter. 
Blood for cytokine measurement was sampled in separate experiments, 
where animals were culled by overdose of anaesthetic and immediately 
upon cessation of circulation had 200 µl blood drawn into EDTA-laced 1ml 
insulin syringes from the hepatic portal vein, supra-hepatic vena cava and left 
ventricle. Blood was processed immediately as per general methods and 
plasma snap frozen on dry ice within 15 minutes of sample collection.  
3.3.2 Reagents 
10X RBC Lysis Buffer (Multi-species) and anti-mouse CD45 (FITC), anti-mouse 
CD11b (Pacific Blue), anti-mouse Ly6G RB6-8C5 (PE), anti-mouse Ly6C (APC) 
and anti-mouse F4/80 (eFluor 780) were from eBioscience (eBioscience Ltd, 
Hatfield, UK). BD FACS Flow sheath fluid and compensation beads (Becton, 
Dickinson and Company, Oxford, UK). Cytokine Bead Array – BD CBA Flex Set 
multiplex panel of beads: Mouse TNF; Mouse IL-6; Mouse MCP-1; Mouse IL-10; 
Mouse IFNg; Mouse IL-1b; Mouse KC (all Becton, Dickinson and Company, 
Oxford, UK). Depletion antibodies InVivoMAb anti-mouse Ly6G (1A8) and 
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InVivoMAb anti-mouse Ly6C (Monts1), both Bxcell (2BScientific Ltd, Heyford, 
UK). Anti-CCR2 (MC-21) and control antibody (MC-68) were generously gifted 
by Prof Matthias Mack, University of Regensburg, Germany. 
3.3.3 Leukocyte phenotyping 
Antibodies were added to 50 µl whole blood, splenocytes or pancreas cell 
extract as per manufacturer’s protocol (CD45/CD11b/L6G/Ly6C for whole 
blood, additional F4/80 for splenocytes and pancreas) and incubated in the 
dark for 30 minutes. Fluorescent panel compensations were generated using 
BD compensation beads according to the manufacturer’s instructions in the 
standard manner. RBC lysis buffer was added for 10 minutes before 
centrifugation, wash and re-suspension in BD FACS Flow sheath fluid. Stained 
cells were immediately analysed using a BD Fortessa multi-colour flow 
cytometer (Becton, Dickinson and Company, Oxford, UK) with a 5-laser set-
up. Data extraction and analysis was undertaken using Flow Jo for Windows. 
Figure 3-1 details the gating algorithms. 
3.3.4 Cytokine measurement 
Cytokine measurements were undertaken in thawed EDTA plasma at a 1:4 
dilution as per manufacturer’s instructions, similar to previous reports (Malla, 
Karrman Mardh et al. 2016). Beads were analysed using a BD Fortessa (Becton, 
Dickinson and Company, Oxford, UK) flow cytometer running FACSDIVA 
software v7, following manufacturer’s manual set-up instructions. Protein 
standards were used to generate standard curves using Prism 7.0c for Mac 
using either linear or non-linear curve fits as appropriate (figure 3-2) and test 
concentrations extrapolated using these curves.  
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3.3.5 Leukocyte depletion 
To ensure effective leukocyte depletion, animals were pre-treated with a 
single intra-peritoneal injection of relevant depletion antibody (500 µg anti-
Ly6G, 500 µg anti-Ly6C or 75 µg anti-CCR2 antibody) 12 hours prior to induction 
of acute pancreatitis. Anti-Ly6G clone 1A8 was used for depletion of 
neutrophils, as this currently has the greatest neutrophil-specificity with minimal 
unwanted monocyte/platelet depletion (Daley, Thomay et al. 2008). 100 µl 
blood was sampled from tail veins of experimental animals prior to induction 
of acute pancreatitis and analysed flow cytometrically to confirm successful 
depletion. Blood was again taken at the time of tissue harvest and analysed 
to confirm persistent depletion of the relevant cell populations. 
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Figure 3-1 Gating strategies in the identification of monocyte, macrophage and neutrophil 
populations in murine whole blood, pancreas and spleen. The initial whole-cell population (left) 
selects the leukocyte population gating on CD45 positivity, whereas monocytes (Ly6C+/CD11b+; 
top right) and neutrophils (Ly6G+/CD11b+; bottom right) are selected from the leukocyte 
population. Cell viabilities >95% for all cell types. 
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Figure 3-2 Standard curves of mean cytokine bead array fluorescence generated from 
recombinant protein standards with associated linear or non-linear regression curves used for 
extrapolation of cytokine concentrations. R2 consistently > 0.99 for all measured cytokines. 
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3.4 Chemokines attract myeloid cells to the inflamed pancreas 
while the liver amplifies systemic cytokine signals 
In order to identify the source of chemokines and cytokines released in the 
early phases of acute pancreatitis blood was sampled from the portal vein 
and thoracic vena cava in mice, immediately following induction of acute 
pancreatitis with 12 hourly injections of cerulein and 12 hours thereafter. A 
panel of 6 pro-inflammatory cytokines was selected based on known 
relevance to leukocyte migration and previous investigations in the context 
of experimental pancreatitis. The final panel measured concentrations of IL-
1b, TNF, CCL2, CXCL-1, IL-6 and IFNg using a cytokine bead assay (CBA) 
analysed by flow cytometry. Except for IFNg, which was consistently below the 
detection threshold of the test, all cytokines were included for analysis. 
Figure 3-3 details chemokine levels 12- and 24-hours following induction of 
experimental acute pancreatitis with 12 hourly injections of cerulein. As 
expected, chemokine concentrations were highest in portal vein blood 
indicating the pancreas as likely source. Chemokine levels in central venous 
blood of pancreatitis animals were indistinguishable from those in control 
animals after 24 h (CCL2, p=0.4326; CXCL2, p=0.7144), suggesting either that 
pancreatic chemokine production/release had ceased by 24 h or that there 
was a negative feedback system between chemokines and their target cells 
to limit the overall inflammatory response. 
Figure 3-4 demonstrates the differences observed with cytokines. All three 
cytokines measured were present in similar, or higher in the case of TNF, 
concentrations in portal and central venous circulation.  As central venous 
blood is a mixture of portal and systemic blood, the finding that there is no 
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significant dilution of cytokine concentrations suggests that the liver is a major 
producer of these cytokines in systemic circulation, and in the case of TNF is 
the main source of the cytokine in systemic circulation. 
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Figure 3-3 Chemokines CCL2 (MCP-1) and CXCL-1 (KC) measured in blood from portal vein, 
thoracic vena cava and left ventricle from mice with acute pancreatitis induced by 12 hourly 
cerulein injections or saline controls. Samples were taken one and 13 hours after the final cerulein 
injection. Comparisons were made by 2-way ANOVA and multiple t-tests using Benjamini, Kriegler, 
Yekutieli false-discovery method. * denotes p<0.05 between anatomical locations and timepoints; 
n ³ 6. 
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Figure 3-4 Cytokines IL-1b and TNF measured in blood from portal vein, thoracic vena cava and 
left ventricle from mice with acute pancreatitis induced by 12 hourly cerulein injections or saline 
controls. Samples were taken one and 13 hours after the final cerulein injection. IL-6 measurements 
were taken from portal and systemic venous blood only. Comparisons were made by 2-way 
ANOVA and multiple t-tests using Benjamini, Kriegler, Yekutieli false-discovery method. * denotes 
p<0.05 between anatomical locations and timepoints; n ³ 6. 
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3.5 Inflammatory monocytes and neutrophils are recruited to the 
pancreas and dampen further chemokine release 
In inflammation research, particularly in acute pancreatitis, an assumption is 
frequently that changes in peripheral blood reflect changes at organ level. 
This is a pragmatic view when investigating human pancreatitis as deep tissue 
samples are impractical, however it is an assumption that can be tested in 
experimental models. 
Figure 3-5 demonstrates changes in numbers of monocytes (Ly6C positive 
cells) and neutrophils (Ly6G positive cells) as a proportion of leukocytes (CD45 
positive cells) or total cells following induction of acute pancreatitis or in saline 
controls in blood, spleen and pancreas. The proportion of neutrophils rises in 
blood following induction of pancreatitis, which is mirrored by a rise of 
neutrophil numbers in the pancreas and spleen. Monocytes, however, reduce 
in number in blood, but increase early in the pancreas and after 24 h in the 
spleen, possibly representing the extravasation of inflammatory cells into their 
target organ and lymphatic system. Neutrophils may be recruited in such 
large numbers from cellular stores that no similar drop is seen in blood. 
To assess roles of classical monocytes (Ly6C positive), inflammatory 
monocytes (CCR2 positive) and neutrophils (Ly6G positive), these cell types 
were individually depleted using monoclonal antibodies. Each monoclonal 
antibody effectively depletes its respective cell type, without significant 
effects on the other (Figure 3-6). Following induction of acute pancreatitis, 
monocyte depletion has no effect on blood neutrophil levels, but neutrophil 
depletion doubles blood monocytes (p=0.0028), suggesting neutrophils 
suppress monocyte expansion via a negative feedback mechanism. On a 
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cytokine level (Figure 3-7), neutrophil depletion drastically increases levels of 
the chemokine KC in circulation, which hints at a possible mechanism for this 
feedback loop. Depletion of inflammatory monocytes, but not classical 
monocytes, increases levels of circulating TNF and CCL2 (MCP-1), suggesting 
an inflammatory monocyte-specific feedback mechanism. 
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Figure 3-5 Monocytes (Ly6C+) and Neutrophils (Ly6G+) as a proportion of leukocytes (CD45+) or 
total viable cells measured with multi-colour flow cytometry. Data points are from whole blood, 
pancreas (collagenase digestion) and spleen (homogenate) from CD-1 Swiss mice 12 and 24h 
following induction of acute pancreatitis with 12 hourly injections of cerulein (50µg/kg, i.p.). 
Comparisons are made to saline control by ANOVA, where red colour of the data set indicates 
p<0.05; n ³ 5. 
12
h
24
h
12
h
24
h
0
2
4
6
8
Blood - Monocytes
%
 L
eu
ko
cy
te
s
Cerulein x12 Saline x12
12
h
24
h
12
h
24
h
0
2
4
6
Spleen - Monocytes
%
 L
eu
ko
cy
te
s
Cerulein x12 Saline x12
12
h
24
h
12
h
24
h
0
5
10
15
20
Spleen - Neutrophils
%
 L
eu
ko
cy
te
s
Cerulein x12 Saline x12
12
h
24
h
12
h
24
h
0
20
40
60
80
100
%
 L
eu
ko
cy
te
s
Blood - Neutrophils
Cerulein x12 Saline x12
12
h
24
h
12
h
24
h
0
1
2
3
Pancreas - Monocytes
%
 V
ia
bl
e 
C
el
ls
Cerulein x12 Saline x12
12
h
24
h
12
h
24
h
0
5
10
15
Pancreas - Neutrophils
%
 V
ia
bl
e 
C
el
ls
Cerulein x12 Saline x12
The Inflammatory Sequence in Acute Pancreatitis 
Peter Szatmary  February 2019 68 
 
  
Co
ntr
ol 
AB
_M
on
oc
yte
s
An
ti L
y6
C_
Mo
no
cy
tes
An
ti C
CR
2_
Mo
no
cy
tes
An
ti L
y6
G_
Mo
no
cy
tes
0.0
0.5
1.0
1.5
2.0
2.5
Pre-AP depletion - monocytes
%
**
***
Co
ntr
ol 
AB
_N
eu
tro
ph
ils
An
ti L
y6
CN
eu
tro
ph
ils
An
ti C
CR
2_
Ne
utr
op
hil
s
An
ti L
y6
G_
Ne
utr
op
hil
s
0
10
20
30
Pre-AP depletion - neutrophils
%
****
Co
ntr
ol 
Mo
no
cy
tes
An
ti L
y6
C 
Mo
no
cy
tes
An
ti C
CR
2 M
on
oc
yte
s
An
ti L
y6
G_
Mo
no
cy
tes
0
1
2
3
4
5
Post-AP depletion - monocytes
%
**
Co
ntr
ol 
AB
 N
eu
tro
ph
ils
An
ti L
y6
C 
Ne
utr
op
hil
s
An
ti C
CR
2 N
eu
tro
ph
ils
An
ti L
y6
G_
Ne
utr
op
hil
s
0
10
20
30
40
Post-AP depletion - neutrophils
****
Figure 3-6 Effect of neutrophil or monocyte depletion on the other cell-type in blood. Blood samples 
were taken from tail vein of CD-1 Swiss mice prior to induction of acute pancreatitis, and from 
cardiac puncture 24h following 12 hourly injections of cerulein (50µg/kg, i.p.). Cell numbers refer to 
event numbers (Ly6G – neutrophils, Ly6C – monocytes) measured by multi-colour flow cytometry 
as a proportion of total leukocyte (CD45+) numbers. All comparisons are to the control group by 
ANOVA, where * denotes p<0.05, ** p<0.01, *** p<0.001 and **** p<0.000; n ³ 6. 
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Figure 3-7 Plasma cytokine levels measured by cytokine bead assay from CD-1 Swiss mice 24 hours 
after induction of acute pancreatitis with 12 hourly injections of cerulein (50µg/kg, i.p.) and 
following depletion of  classical monocytes (Ly6C), inflammatory monocytes (CCR2) and 
neutrophils (Ly6G) with a single injection of the relevant monoclonal antibody 12h prior to induction 
of pancreatitis. All comparisons are to the control group by ANOVA, where * denotes p<0.05, ** 
p<0.01, *** p<0.001 and **** p<0.0001; n ≥ 6. 
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3.6 Monocytes have a greater role in pancreatic injury, whereas 
neutrophils make a greater contribution to lung injury. 
To assess the roles of the three myeloid cell types (classical monocytes, 
inflammatory monocytes and neutrophils) on the pathogenesis of acute 
pancreatitis, the effect of cell depletion on pancreatic and lung 
myeloperoxidase activity, trypsin activity, plasma amylase levels (Figure 3-8) 
and pancreatic histopathology was measured (Figure 3-9). Depletion of 
classical monocytes led to a statistically significant reduction in pancreatic 
(but not lung) MPO as well as plasma amylase levels. Inflammatory monocyte 
depletion reduced lung MPO and pancreatic trypsin activity levels as well as 
plasma amylase, and neutrophil depletion reduced pancreatic and lung 
MPO as well as pancreatic trypsin activity levels. Only monocyte depletion 
demonstrated a statistically significant improvement in pancreatic 
histopathology, with the most notable improvement being a reduction in 
pancreatic necrosis.  
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Figure 3-8 Biochemical parameters (pancreas and lung MPO activity, pancreatic trypsin activity 
and plasma amylase) from organ homogenates and plasma of CD-1 Swiss mice after induction of 
acute pancreatitis with 12 hourly injections of cerulein (50µg/kg, i.p.) and depletion of classical 
monocytes (Ly6C), inflammatory monocytes (CCR2) and neutrophils (Ly6G) using specific 
monoclonal antibodies. All comparisons are to the control group by ANOVA, where * denotes 
p<0.05, ** p<0.01, *** p<0.001 and **** p<0.0001; n ³ 6. 
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Figure 3-9 Histopathological scores from pancreata of CD-1 Swiss mice pre-treated with depletion 
of classical monocytes (Ly6C), inflammatory monocytes (CCR2) and neutrophils (Ly6G) using 
specific monoclonal antibodies. All comparisons are to the control group by ANOVA, where * 
denotes p<0.05, ** p<0.01, *** p<0.001 and **** p<0.0001; n ³ 6. 
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3.7 Discussion 
The combined actions of classical monocytes, inflammatory monocytes and 
neutrophils in acute pancreatitis secondary to cerulein hyperstimulation are 
such as to exacerbate pancreatic injury in the short term (ie within 24 hours). 
The actions of each individual cell type, however, appear to be more 
nuanced. Chemokines including CXCL-1 (KC) and CCL2 (MCP-1) are released 
into the portal vein, resulting in recruitment of monocytes and neutrophils to 
the pancreas. This or other signals lead to cells within the liver, possibly Kupffer 
cells (Gloor, Blinman et al. 2000; Folch-Puy 2007); hepatic stellate cells 
(Stefanovic, Brenner et al. 2005); or peritoneal macrophages (Rehermann 
2016), to produce and release cytokines (TNF and IL-1b) into the systemic 
circulation. Although generally thought of as redundant signalling, depletion 
of individual cell types leads to the increase in concentrations of individual 
cytokines (Neutrophils – KC, inflammatory monocytes – CCL2 and TNF, 
classical monocytes – IL-1b), raising the possibility of cell-specific feedback 
pathways. Furthermore, the pattern of injury in experimental acute 
pancreatitis is specific to each cell type, with neutrophils contributing 
predominantly to protease activation and lung injury, but monocytes being 
primarily responsible for pancreatic cellular injury and the rise in systemic 
amylase. 
These data are of interest, as they hint at a more nuanced pathogenesis than 
previously assumed, which opens new avenues for clinical exploitation. 
However, it needs to be regarded with due caution. CCL2 (but not CCR2) 
deficient animals, for example, show a blunted response to cerulein-induced 
acute pancreatitis (Frossard, Lenglet et al. 2011). However, animals deficient 
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in CCR2, i.e. those unable to recruit inflammatory monocytes, exhibit greater 
neutrophil infiltration and hyperglycaemia following chronic cerulein 
administration (Nakamura, Kanai et al. 2013). Data from our study 
demonstrates the cytokine feedback mechanisms as well as the controls that 
monocytes place on neutrophils and vice-versa. Blockade of a single factor 
can, therefore, lead to an unexpected increase in another. The varied 
responses measured in response to different cytokine inhibitors may reflect the 
different roles of different cell types at different stages in the pathogenesis of 
pancreatitis, and a cell such as the neutrophil that is injurious in the short term 
and in its local micro-environment may actually be acting to limit wider organ 
injury. A similar phenomenon has been observed in sepsis, where neutrophils 
lead to intravascular thrombosis in hepatic sinusoids to limit the spread of 
micro-organisms (Clark, Ma et al. 2007). 
The use of a single mouse model of acute pancreatitis – cerulein 
hyperstimulation – is a clear limitation of this study. However, it is a reliable and 
extremely reproducible model, and avoids the need for laparotomy which in 
itself leads to tissue injury and inflammation. While 12 hourly injections of 
cerulein produce comparable degrees of pancreatic injury (Huang, Cane et 
al. 2017) and systemic DAMP release (Ou, Cheng et al. 2015) as retrograde 
perfusion of the bile duct with bile acids, it does not produce a significant 
systemic inflammatory response, which is reflected by the relatively low levels 
of cytokines measured (Szatmary and Gukovsky 2016). The method of 
depletion used led to an effective reduction in the cell type in question that 
lasted for the duration of the experiment in the case of neutrophils and 
classical monocytes. Total levels of monocytes had partially recovered by the 
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end of the experiment when depleting inflammatory monocytes alone. This 
could indicate that there is a pool of inactive monocytes that only express 
CCR2 when activated, making antibody-mediated depletion in an untreated 
animal ineffective. In any case, it suggests that the effects of CCR2 depletion 
could have been even more pronounced if it had been achieved more 
effectively. 
Sampling from multiple sources (blood, spleen and pancreas), demonstrates 
very well how changes in blood do not always reflect changes in the target 
tissue, although the changes in the target organ are consistent and 
predictable. This is likely to be highly relevant for human disease. Moreover, it 
has been demonstrated that measurements of leukocyte populations vary 
greatly within the same animal depending on sampling site (Nemzek, Bolgos 
et al. 2001), presumably due to changes to endothelial adhesion molecules. 
This can further limit the comparability of experimental studies, or indeed 
human studies using peripheral and central blood interchangeably. 
3.8 Summary 
Pancreatic injury results in the release of chemokines that lead to the 
recruitment of neutrophils as well as inflammatory and classical monocytes to 
the pancreas, where the resulting cellular inflammation exacerbates the initial 
injury. These early responder cells then dampen further cytokine release and 
promote resolution of inflammation in complex interactions between 
themselves and through cytokine signalling. A better understanding of these 
interactions could help to design strategies to improve monitoring and 
influence the pathogenesis of acute pancreatitis in the future. Lessons about 
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the importance of sampling site and timing should be applied to human trial 
designs.  
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4 Extracellular Histones Contribute to Disease 
Severity in Acute Pancreatitis 
4.1 Visual abstract 
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4.2 Background 
Pancreatic acinar cell injury leading to the release of pro-inflammatory 
cytokines and recruitment of immune cells is a well investigated process 
(Habtezion 2015; Habtezion and Algul 2016; Gukovskaya, Gukovsky et al. 
2017) and the cellular events are described in greater details still in the 
previous chapter. Acute pancreatitis is itself associated with systemic release 
of histones, the amount correlating with disease severity in animal models (Ou, 
Cheng et al. 2015), however the precise source of histones is not known. 
Necrotic acinar cells seem a likely candidate, as specific neutrophil depletion 
had little effect on pancreatic injury as seen in the previous chapter. 
Extracellular histones also contribute to lung injury when injected systemically 
(Saffarzadeh, Juenemann et al. 2012; Zhang, Guan et al. 2016), leading to 
pulmonary vascular endothelial activation and neutrophil trapping. As well as 
lung injury, extracellular histones can induce cardiac, hepatic and renal injury 
(Kawai, Kotani et al. 2016) in mice, a phenomenon reminiscent of the multi-
organ failure seen in clinical severe acute pancreatitis. One of the functions 
of C-reactive protein (CRP), the best current biomarker in the prediction of 
severity of acute pancreatitis, is to bind and detoxify circulating histones 
(Abrams, Zhang et al. 2013), suggesting a rise in CRP might be in response to 
a rise in circulating histones. 
This chapter aims to investigate the utility of measuring circulating histones as 
nucleosomes in human acute pancreatitis, determine the source of 
extracellular histones in circulation during acute pancreatitis using a cerulein 
model and evaluate the effects of exogenous histones in the pathogenesis of 
the disease. 
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4.3 Specific methods 
4.3.1 Human samples 
Human plasma samples from the NIHR Liverpool Pancreas Acute Pancreatitis 
Biobank from 50 randomly selected patients was analysed (see general 
methods for a detailed sample description). Nucleosome levels were 
measured using the Roche Cell Death Detection ELISA with minor modification 
from the manufacturer’s instruction as previously described (Abrams, Zhang 
et al. 2013). Absorbance values were recorded using a BMG POLARstar 
Omega Microplate Reader (Imgen Technologies, New York, USA) and 
reported as relative to the lowest recorded value. Disease severity (final 
severity classified according to the revised Atlanta classification (Banks, Bollen 
et al. 2013)) and CRP at 24 and 48 hours after admission was also collected 
and used to calculate ROC curves using Prism 7.0c for Mac. 
4.3.2 In vivo experiments 
Both mild (4 injection) and severe (12 injection) models of cerulein acute 
pancreatitis were used (see general methods). FITC-tagged histones (20 
mg/kg) were administered via the tail vein immediately following the last 
cerulein injection using the 4-injection model only. Animals were sacrificed 6 
hours following administration of the first cerulein injection. Organs were 
harvested, washed in PBS and briefly dried on sterile gauze. Organs were 
imaged using an IVIS Spectrum preclinical imaging system (Perkin Elmer, 
Waltham, MA, USA) utilizing the epifluorescence function collecting signal for 
8 seconds. In selected experiments, calf-thymus histones (20 mg/kg) or PBS 
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(200 µl) were administered in the same way as above. Animals were sacrificed 
and tissues harvested for further analysis 12 hours after the first cerulein 
injection. For portal, central venous and arterial blood sampling animals 
received an overdose of pentobarbital, abdominal and thoracic cavities 
where opened and plasma samples taken into EDTA syringes containing 1% 
v/v heparin from portal vein, thoracic inferior vena cava and left ventricle. 
Histone quantification was performed by Western blot and densitometry 
performed in ImageJ (Schneider, Rasband et al. 2012). 
4.3.3 Reagents 
For some experiments histones were conjugated with fluorescein 
isothiocyanate (FITC) and passed through an ion exchange column to 
remove excess dye according to established procedures (Fattahi, Grailer et 
al. 2015). FITC-conjugated histones were generated and gifted by Dr Simon 
Abrams (see acknowledgements). Cell Death Detection ELISA was from 
Roche (Roche Diagnostics Ltd, Burgess Hill, UK). 
4.4 Circulating nucleosome levels correlate with disease severity 
in human acute pancreatitis 
Nucleosomes, i.e.: DNA-associated histones, are easier to measure than 
histones themselves, as nucleosomes can be measured using a simple 
sandwich ELISA, whereas histones are measured using qualitative or 
quantitative Western blotting. Therefore, levels of circulating nucleosomes 
were measured in plasma from 50 patients (mild and/or moderate, n=36; 
severe, n=14) with acute pancreatitis selected at random and obtained from 
the NIHR acute pancreatitis biobank. Levels were then correlated with data 
on disease severity and C-reactive protein concentrations. 
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Levels of circulating nucleosomes were significantly higher in severe, 
compared to mild/moderate disease (Figure 4.1, P<0.0001). ROC curve 
analysis revealed 0.87 accuracy (Figure 4.1, P=0.001) in discriminating 
between mild/moderate and severe acute pancreatitis on admission, 
compared to an accuracy of 0.72 (P=0.049) and 0.82 (P=0.0046) when using 
CRP measured within 24 and 48 hours of admission respectively. This highlights 
the potential clinical utility of measuring circulating nucleosome levels in 
predicting persistent organ failure in acute pancreatitis. These findings were 
confirmed by direct measurement of histones by quantitative Western blot 
(Figure 4.1), leading to an expansion of the dataset and subsequent 
publication  (Liu, Huang et al. 2017). 
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Figure 4-1 A) Levels of circulating nucleosomes relative to each other in plasma from patients with 
mild, moderate or severe acute pancreatitis according to the revised Atlanta classification of 
Acute Pancreatitis. B) Receiver operator characteristic of circulating nucleosomes on admission, 
as well as CRP on admission and at 48 hours in predicting severe disease at any time during 
admission. C) Quantitative Western blot of circulating histones in patients with mild, moderate or 
severe acute pancreatitis. Comparisons between two groups were done using the Mann-Whitney 
U test, where * denotes p<0.05, ** p<0.01, *** p<0.001 and **** p<0.0001; n = 50. 
0 50 100
0
50
100
100% - Specificity%
S
en
si
tiv
ity
%
ROC Curve of Circulating Nucleosomes
cfDNAHist24h - AUC 0.87; P=.0001
CRP48h          - AUC 0.82; P=.0046
CRP24h          - AUC 0.72; P=.049
Mild/Moderate Severe
0
20
40
60
80
H
is
to
n
es
 (
µ
g
/m
l)
Circulating Histones
****
Mild/Moderate Severe
0
50
100
150
R
el
at
iv
e 
N
uc
le
os
om
e 
C
on
ce
nt
ra
tio
n
Circulating Nucleosomes
****
A 
B 
C 
Extracellular Histones Contribute to Disease Severity in Acute Pancreatitis 
Peter Szatmary  February 2019 83 
4.5 The liver is the primary source of circulating histones in 
cerulein pancreatitis 
It is easy to assume equal distribution of soluble factors in circulation. However, 
as demonstrated in the previous chapter, soluble molecules released in 
response to injury that carry a signalling function can vary greatly in 
concentration depending on the location of production/release. The 
hypothesis with histones in the context of acute pancreatitis was that histones 
are either released passively as a consequence of acinar cell necrosis, or 
actively as a result of NETosis. To test this hypothesis, plasma was sampled from 
murine portal vein and vena cava blood following induction of acute 
pancreatitis with 12 hourly i.p. injections of 50 µg/kg cerulein. Surprisingly, there 
was a 20-fold greater concentration of histone H3 in post-hepatic central 
venous blood compared to post-pancreatic portal blood or arterial (cardiac) 
blood (Figure 4.2; P<0.05). 
To investigate this phenomenon further, systemic levels of the hepatocellular 
enzyme alanine aminotransferase (ALT) were measured and livers of 
pancreatitis and control animals subjected to histopathological analysis. 
Plasma levels of ALT were elevated 4-fold in cerulein pancreatitis compared 
to controls, and while liver histopathology did not demonstrate any hepato-
cellular necrosis, it did reveal vacuolisation (consistent with cellular stress) in 
oxygen-poor zone 3 (Figure 4-3). 
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Figure 4-2 A) Western blot of histones in murine plasma after induction of acute pancreatitis with 
12 i.p. injections of 50 µg/kg cerulein, sampled from portal vein, vena cava and left ventricle in the 
same animal. Parallel lines link bands from the same animal. B) Relative density of histone H3 bands 
from different sample locations. All comparisons are to each other group by ANOVA, where * 
denotes p<0.05; n = 6. 
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Cerulein 
Figure 4-3 A) Plasma ALT levels in mice with acute pancreatitis induced by 12x i.p. injections of 50 
µg/kg cerulein and saline controls. B) Histopathological slide of liver (x20 magnification) stained 
with Haematoxilin and Eosin, denoting perfusion zones I-III and direction of blood flow (yellow 
arrow). Comparisons are made using Student’s t-test, where * denotes p<0.05; n ≥ 6. 
A 
B 
Saline 
III 
II 
I 
III 
II 
I 
Extracellular Histones Contribute to Disease Severity in Acute Pancreatitis 
Peter Szatmary  February 2019 86 
4.6 Systemically administered histones exacerbate pancreatic 
injury in mild oedematous experimental pancreatitis 
Having established a correlation between histones in circulation and severity 
of acute pancreatitis in patients, as previously in cerulein pancreatitis (Ou, 
Cheng et al. 2015), and identified an extra-pancreatic source for histones, the 
possibility of a causal relationship between circulating histones and severity of 
pancreatitis presents itself. To test causality, a milder form of experimental 
acute pancreatitis was induced using 4x hourly i.p. injections of cerulein 
together with a sub-lethal dose (20 mg/kg) of histones i.v (tail vein) together 
with the 4th injection of cerulein. Serum biochemistry and pancreas histology 
was evaluated 12 hours after induction of pancreatitis, allowing comparison 
with the severe model. 
Histone administration alone did not raise serum amylase or pancreatic MPO 
activity levels above control, but co-administration of histones in the context 
of mild cerulein-induced pancreatitis markedly increased pancreatic MPO 
activity as well as inflammatory cell infiltrates and acinar cell necrosis beyond 
control, as confirmed by blinded histopathological scores (Figure 4-3). 
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Figure 4-4 A) Serum amylase concentration, B) pancreatic and C) lung myeloperoxidase activity 
and D) blinded histopathological assessment of the pancreas (oedema, infiltration and necrosis) 
in experimental acute pancreatitis induced by 4x hourly i.p. injections of 50 µg/kg cerulein or saline 
controls, both with and without co-administration of 20 mg/kg i.v. calf thymus histones. E) 
Representative micrograph of histologic appearance of pancreata of treated animals. All 
comparisons by ANOVA, where * denotes a difference of p<0.05 to control and # denotes a 
difference of p<0.05 to cerulein; n ³ 6. 
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4.7 Systemically administered histones concentrate within an 
inflamed pancreas 
The results above suggest administering histones systemically can increase 
necrosis and inflammation within the pancreas itself. The mechanism for this is 
not clear. Previous work, using FITC-labelled histones injected into the tail vein 
and then measuring fluorescence in organ homogenate suggested that 
systemically injected histones concentrated within the lung (Fattahi, Grailer et 
al. 2015). The results above do not demonstrate elevation of lung MPO 
following intravenous administration of histones, making significant pulmonary 
injury as an indirect cause of exacerbated pancreatic necrosis (e.g. through 
hypoxia) unlikely. 
To identify the site of action of intravenously injected histones, FITC-labelled 
histones were injected into the tail veins of C57Bl6/J mice, similarly after 4x 
hourly i.p. injections of 50 µg/kg cerulein or saline. Animals were sacrificed 6 
hours after the first i.p injection and internal organs (heart, lung, liver, 
pancreas, spleen, kidneys and bladder) were extracted and imaged using an 
IVIS Spectrum epifluorescence chamber. The only detectable FITC signal was 
in pancreata of cerulein-treated mice (Figure 4-5). There was marked 
autofluorescence in gall bladders and bladders of mice, which was present 
irrespective of FITC administration. Critically, there was no signal in pancreata 
of saline-treated animals, or when injecting unconjugated FITC (20 g/kg) as a 
control, indicating concentration of histones within the inflamed pancreas 
and not hyperaemia, or an exudative mechanism. There was no detectable 
signal in heart, lungs, liver, kidneys or spleen in cerulein or control animals. 
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Figure 4-5 A) Epifluorescent image of murine organs following i.v. injection of FITC-labelled histones 
in cerulein AP or saline controls; inset is close-up view of pancreas and spleen. Fluorescence 
intensity in pancreata of B) cerulein or C) saline treated animals with or without administration of 
FITC-labelled histones. Fluorescence intensity of all extracted organs (except bladder) in D) cerulein 
AP or E) saline controls. All comparisons are by ANOVA (parametric data) or Kruskall-Wallace test 
(non-parametric). * denotes p<0.05, and ** p<0.01; n ≥ 5. 
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4.8 Discussion 
Extracellular histones are known mediators of acute inflammation (Allam, 
Kumar et al. 2014; Kawai, Kotani et al. 2016). As nuclear proteins, a rise in 
plasma concentration would be expected in a disease marked by tissue 
necrosis such as acute pancreatitis, especially when taking active release by 
infiltrating inflammatory cells into account (Merza, Hartman et al. 2015). 
Indeed, the data presented here confirms the correlation between circulating 
nucleosomes and histones already reported in experimental models of AP 
(Ou, Cheng et al. 2015) as well as in patients (Penttila, Rouhiainen et al. 2016). 
It goes further to confirm the same correlations holds for circulating histone H3 
and that this increase is detectable within 24 hours of admission to hospital, 
while the absolute concentration is more accurate in predicting disease 
severity than the current best biomarker - CRP measured at 48 hours. 
Current understanding leads to the hypothesis that this rise in circulating 
histones in acute pancreatitis is due to a combination of pancreatic cellular 
necrosis and intra-pancreatic extracellular trap release, however this would 
mean the highest measurable histone concentration in any given animal with 
acute pancreatitis should be in the first common drainage channel – the 
portal vein. The data presented here clearly demonstrate peak histone 
concentrations in the post-hepatic vena cava, concluding that the liver is the 
predominant source of histones in circulation. While there is a concomitant 
rise in ALT and structural hepatocyte damage in poorly oxygenated zone 3, it 
is worth noting that the role of ALT in human acute pancreatitis is less clear, as 
the two commonest causes of human acute pancreatitis (gallstones and 
ethanol) can independently affect ALT levels. Apoptosis of lymphocytes (Bell 
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and Morrison 1991) in systemic circulation has also been postulated as primary 
cause of the rise in circulating histones in AP (Ou, Cheng et al. 2015) or sepsis 
(Liu, Ni et al. 2013). The relatively low histone concentrations in arterial blood, 
however, adds further support to the liver as primary source in our model and 
indeed allows us to hypothesise that the pulmonary circulation acts as a filter 
for circulating histones. It is possible that rather than hepatocyte injury, resident 
Kupffer cells or peritoneal macrophages, recruited to the liver in inflammation 
(Niu, Bian et al. 2016; Rehermann 2016), contribute to the release of histones 
in response to portal vein DAMPs as previously shown in vitro (Chen, Fu et al. 
2015). This interpretation would be supported by data showing reduced liver 
injury in experimental AP following Kupffer cell depletion (Zhang, Dang et al. 
2010) as well as reduced lung injury seen in AP with Kupffer cell inhibition (Liu, 
Cui et al. 2006). As one of the earlier descriptions of the role of hepatic NETs 
was to limit systemic spread of micro-organisms in sepsis (McDonald, Urrutia et 
al. 2012) and bacterial translocation resulting from intestinal barrier failure is a 
hallmark of human and experimental acute pancreatitis (Rychter, van Minnen 
et al. 2009; Koh, Jeon et al. 2012), portal sepsis may be the principle 
determinant of hepatic histone release. This hypothesis would provide a 
mechanistic link between pancreatitis severity and hepatic NET/histone 
release, and a potential explanation how pancreatic infection could 
contribute to disease severity (Petrov, Shanbhag et al. 2010). The use of only 
a single experimental model of acute pancreatitis is an obvious limitation 
when making conclusions about the source of histones in acute pancreatitis. 
Irrespective of the primary source of circulating histones, the data here 
presented confirm a causal relationship between circulating histones and 
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disease severity in acute pancreatitis. Systemic injection of histones not only 
leads to a concentration of histones within the inflamed pancreas but 
exacerbates organ injury. The apparent contradiction with the only previous 
bio-distribution study of circulating histones (Fattahi, Grailer et al. 2015), which 
used a very similar methodology, can be explained by the differences in 
disease models. Fattahi and colleagues used an experimental sepsis model 
and found histone concentration within the lung. They also used a higher dose 
of histones (45 mg/kg), much closer to the lethal dose of 75 mg/kg, which has 
been shown to lead to rapid death within hours from pulmonary oedema and 
alveolar haemorrhage (Abrams, Zhang et al. 2013). Fattahi’s finding is also 
consistent with the finding that histones only concentrate within an injured 
and inflamed pancreas. The fact that un-conjugated FITC does not lead to a 
similar increase in fluorescence indicates that this is an active process, rather 
than leakage into the tissues as oedema. It is possible that extravasation of 
net-positively charged histones is facilitated by the exposure of net-negatively 
charged proteoglycans such as heparin sulphate. Given that histones 
themselves exert antimicrobial activity and that infection of necrosis 
significantly increases mortality in necrotizing pancreatitis (Petrov, Shanbhag 
et al. 2010; Hackert and Buchler 2016; Werge, Novovic et al. 2016), this 
mechanism may even offer some survival benefit at the cost of exacerbating 
disease in the short term. 
4.9 Summary 
Collectively, these data demonstrate circulating histones are important early 
mediators of pancreatitis severity and implicate the liver as the primary source 
in circulation; circulating histones concentrate within the inflamed pancreas 
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and actively contribute to pancreatic acinar cell necrosis and pancreatic 
inflammation. 
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5 Histones are Toxic to Pancreatic Acinar Cells 
5.1 Visual abstract 
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5.2 Background 
Data in the previous chapter demonstrate how histones are released into the 
systemic circulation by cells within the liver, although it is not clear whether this 
is an active or passive process involving hepatocytes, or resident immune 
cells. Nevertheless, there is a measurable increase in circulating histones in 
acute pancreatitis. Furthermore, histones injected into the systemic 
circulations of mice in the context of cerulein pancreatitis concentrate within 
the inflamed pancreas to exacerbate pancreatic injury. The mechanism by 
which histones contribute to cellular necrosis, however, remains unclear. 
Histones are positively charged nuclear chaperone proteins that interact with 
the negatively charged phosphate backbone of DNA to form tightly packed 
nucleosomes within the nucleus. Modification and breakdown of linker 
histones within neutrophil nuclei contributes to the massive nuclear volume 
increase seen immediately prior to NETosis (Papayannopoulos, Metzler et al. 
2010; Thomas, Whangbo et al. 2014). Similarly, histones in solution have been 
shown to interact with negatively charged proteins (Lete, Sot et al. 2014) and 
phospholipids (Pereira, Marco et al. 1994) at the surface of cells, whereas they 
do not interact with zwitterionic phospholipids like phophatidylcholine 
(Pereira, Marco et al. 1994). Addition of a negatively charged phosphate 
head group increases the strength of histone binding as measured by 
calorimetry (Lete, Sot et al. 2014). The hypothesis, therefore, must be that 
histones interact with acinar cell membranes in a charge-dependent 
mechanism. 
In lipid bilayers, histone fragments have been shown to form membrane-
spanning pore-like structures (Kleine, Lewis et al. 1997) that increase 
Histones are Toxic to Pancreatic Acinar Cells 
Peter Szatmary  February 2019 96 
conductance to polyvalent cations such as calcium (Kleine, Lewis et al. 1997; 
Lete, Sot et al. 2014), leading to rapid cellular necrosis. Negatively charged 
acute phase proteins (such as CRP (Abrams, Zhang et al. 2013)), DNA (Lete, 
Sot et al. 2014), innate polysaccharides such as heparin (Fuchs, Bhandari et 
al. 2011) and synthetic macromolecules such as the polypeptide poly-
glutamic acid (Gamberucci, Fulceri et al. 1998) all compete with membrane 
phospholipids and prevent histone integration and toxicity. Bactericidal 
properties of histone fragments are dependent on their ability to form 
amphipathic a-helices – potential membrane spanning domains – however 
no such analyses have been performed on mammalian cells to date (Koo, 
Kim et al. 2008). 
The ability to form trans-membrane pores is of critical interest in acute 
pancreatitis, due to the possibility of inducing calcium entry into acinar cells. 
Calcium entry has been shown to be an essential early mechanism in acinar 
damage (Ward, Petersen et al. 1995; Booth, Mukherjee et al. 2011) and 
inhibition of calcium entry protects from acinar cell death in several 
experimental models (Wen, Voronina et al. 2015). Indeed, histones have been 
observed to increase calcium conductance across the membranes of several 
other cell types and artificial membranes (Gamberucci, Fulceri et al. 1998). 
This chapter explores the hypothesis that histones interact with pancreatic 
acinar cells in a charge-dependent manner, leading to membrane 
integration, plasmallemma disruption and cell death through unregulated 
calcium entry. 
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5.3 Specific methods 
5.3.1 Experimental animals 
Male CD1 Swiss mice (age 8-10 weeks, weight 30-35 g) were purchased from 
Charles River UK Ltd (Margate, Kent, UK), housed in a pathogen-free unit with 
12 h light-dark cycles and free access to standard lab chow and water. 
Pancreatic acinar cells were freshly isolated and cell death experiments 
conducted as set out in the general methods. 
5.3.2 Cellular Ca2+ measurements 
Murine acinar cells were loaded and incubated with fluo-4 (5 µM) or fura-2 (5 
µM) Ca2+-sensitive dyes as previously described (Voronina, Collier et al. 2015). 
Cells were visualised using a Zeiss LSM 510 (Zeiss Microscopy, Cambridge, UK; 
Ex 488 nm/Em 520 nm) or Till Photonics imaging system (Till Photonics Gmbh, 
Germany; Ex 340 nm; 360 nm; 380 nm/Em 510 nm) in a perfusion-chamber set-
up and challenged with relevant doses of calf-thymus histones. Data for each 
excitation wavelength as well as the ratio of 340 to 380 excitation were 
collected. 
5.3.3 Reagents 
Calf-thymus histones as well as human recombinant histone H2B, H3 and H4 
were purchased from Sigma (Sigma-Aldrich, Gilliangham, UK). Fluo4-AM and 
Fura-2-AM were purchased from ThermoFisher  (Thermo, Rockford, USA). Non-
specific poly-acetylation of histones was achieved by addition of a molar 
excess of acetic anhydride, similar to established protocols (Fojo, Reuben et 
al. 1985). Histones were recovered by solvent evaporation in a fume cabinet 
and resuspended in PBS prior to use. For some experiments histones were 
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conjugated with fluorescein isothiocyanate (FITC) and passed through an ion 
exchange column to remove excess dye according to established 
procedures (Fattahi, Grailer et al. 2015). FITC-conjugated histones were 
generated and gifted by Dr Simon Abrams. 
5.4 Histones induce pancreatic acinar cell death in a time and 
dose-dependent manner 
To test the hypothesis that histones induce pancreatic acinar cell necrosis at 
concentrations relevant to acute pancreatitis, freshly isolated murine 
pancreatic acinar cells were seeded onto a 96 well plate in the presence of 
0.1% PI and fluorescent readings taken every minute for 150 minutes. Calf-
thymus histones were added to the cell solution after 30 minutes at 
concentrations selected based on measurements in murine plasma from 
different experimental models of acute pancreatitis (Ou, Cheng et al. 2015). 
The lowest histone concentration (50 µg/ml) represents plasma measurements 
in cerulein pancreatitis, and the highest concentration (200 µg/ml) retro-
ductal infusion with tauro-lithocholate. All three concentrations of 
extracellular histones lead to a rapid increase in PI-related fluorescence, with 
peak fluorescence measured around one hour after histone application 
(figure 5-1), before reaching a plateau. When looking at maximal PI-related 
fluorescence compared to digitonin cell-lysis, 200 µg/ml histones result in near 
total permeabilization of acinar cells within 60 minutes, and even 50 µg/ml 
lead to permeabilization of 50% of cells. This finding was confirmed imaging 
acinar cells one hour after histone treatment with a confocal microscope. 
There is a dose-dependent increase in cell permeabilization, as well as an 
unusual pattern of PI-related fluorescence, with not only cell nuclei but also 
cell membranes fluorescing (figure 5-2). 
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As calf-thymus histones are a mixture of core and linker histones, the possibility 
that individual components of this mixture differentially affected the histones 
ability to induce cell death was investigated. Repeating the cell death 
experiments with recombinant human histones H2B, H3 and H4, all three core 
histones were able to induce cellular necrosis (figure 5-1), but histone H3 did 
so much more effectively than the other core histones at the higher 
concentration.  
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Figure 5-1 A) Propidium iodide-related fluorescence in freshly isolated murine pancreatic acinar 
cells following administration of different doses of calf-thymus histones over time (mean +/- SEM), 
as measured on a POLARStar multiwall plate reader. Maximum propidium iodide-related 
fluorescence in response to increasing doses of B) calf-thymus, or C) human recombinant histones. 
All comparisons are by ANOVA. * denotes p<0.05, ** p<0.01 and *** p<0.001. Experiments 
performed in triplicate; n ≥ 4 experimental repeats. 
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Figure 5-2 Confocal micrograph of freshly isolated murine pancreatic acinar cells 60 minutes 
following treatment with different concentrations of calf-thymus histones. Fluorescence images 
represent signals due to Hoechst 3342 (blue) membrane permeable nuclear dye and Propidium 
Iodide (red), membrane impermeable nuclear dye. 
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5.5 The histone-acinar cell membrane interaction is mediated by 
charge 
To confirm that histones interact with the cell membrane in a charge-
dependent manner before inducing cell death, FITC-labelled histones were 
added to clusters of freshly isolated murine acinar cells in the presence of the 
membrane-impermeable nuclear dye PI and imaged with a confocal 
microscope. Histones concentrate within acinar cell membranes immediately 
following addition to the solution without any increase in PI signal. Over the 
next few minutes, some cells swell and become permeable to PI, whereas 
others in the same cluster remain apparently intact (figure 5-3).  
Repeating the cell death experiment with poly-acetylated histones, a 
modification designed to reduce their overall net-positive charge, reduces 
their ability to induce membrane permeabilization and cell death. Similarly, 
co-administration of macromolecules with an overall negative charge 
protects acinar cells from injury. This protective effect can be overcome by 
increasing the histone concentration, suggesting a competitive inhibition 
mechanism (figure 5-3). The protective effect of macromolecules is apparent 
in inert macromolecules (poly-glutamic acid) as well as the physiological 
protein albumin.  
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Figure 5-3 A) Representative confocal micrograph of a cluster of murine pancreatic acinar cells 
over time following treatment with FITC-labelled histones; FITC (green), PI (red). Maximal recorded 
PI-related fluorescence in freshly isolated murine pancreatic acinar cells after administration of 
different doses of calf-thymus histones following B) poly-acetylation or C&D) in the presence of 
negatively charged macromolecules. All comparisons are by ANOVA. * denotes p<0.05, ** p<0.01 
and *** p<0.001. Experiments performed in triplicate; n ³ 4 experimental repeats. 
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5.6 Histones increase calcium conductance across acinar cell 
membranes 
As histones have been shown to induce or form non-specific cationic pores in 
cell membranes and lipid bilayers, the effect of histones on acinar cell calcium 
conductance was investigated. Using the calcium-sensing fluorescent dye 
fluo4-AM(Murphy, Criddle et al. 2008), freshly isolated murine pancreatic 
acinar cells were loaded with dye and imaged using a confocal microscope. 
An increase in fluorescence signal indicates an increase in intracellular 
calcium concentration [Ca2+]i. Over 80% of observed cells exhibited multiple 
typical Ca2+ spikes, together with a dramatic decrease in the signal baseline. 
Cells with the greatest drop in signal baseline exhibited morphological 
changes consistent with cell death on the transmitted image (figure 5-4). 
Fluo4-AM has a molecular weight of around 1 kDa, similar to the 0.67 kDa of 
PI, raising the possibility that the drop in baseline fluorescence was not 
secondary to changes in [Ca2+]i, but rather a result of cellular dye loss through 
membrane leakage. To test this hypothesis, the experiment was repeated 
using the same setup, except with fura 2-AM as opposed to fluo4-AM. Fura 2-
AM similarly has a molecular weight of 1 kDa, but exhibits a ratiometric 
response to changes in [Ca2+], with the signal at 340 nm excitation increasing 
in proportion with [Ca2+], and inverse proportion at 380 nm excitation. 
Moreover, it has a [Ca2+]-insensitive isosbestic point at 360 nm, thus allowing 
differentiation of the [Ca2+] and dye-concentration related effects on signal 
strength. Figure 5-4 depicts a representative trace of all the typical responses 
found in acinar cells. Shortly after administration of histones, cells experience 
true calcium spikes (positive signal changes at 340 nm excitation mirrored by 
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negative signal changes at 380 nm excitation) with no change in 360 nm 
signal strength, suggesting constant dye concentration. While some cells will 
return to baseline signal levels after the initial spike, most exhibit calcium 
plateaus at increasing [Ca2+] with each calcium spike. All cells then 
experience signal loss in all three channels, indicative of dye extravasation 
from the cells.  
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Figure 5-4 Freshly isolated murine pancreatic acinar cell cluster loaded with calcium sensitive dye 
A) fluo4-AM or B) the ratiometric calcium-sensitive dye fura-2 AM, following treatment with calf-
thymus histones. F1/F0 signal over time. 
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5.7 Pancreatic acinar cell membrane integrity is disrupted by 
extracellular histones in a calcium-independent manner 
While histones clearly increase calcium conductance in murine pancreatic 
acinar cells, in a manner that at least initially leads to an appropriate cellular 
response of calcium potentiation and clearance (Wen, Voronina et al. 2015), 
the ultimate result is rapid membrane permeabilization to substances of up to 
1 kDa. While [Ca2+]i is critical in the pathogenesis of acinar cell injury in acute 
pancreatitis (Criddle, Gerasimenko et al. 2007), it is unlikely that a cell could 
recover from such an insult irrespective of the effects on calcium homeostasis. 
To test this hypothesis, the fura 2-AM experiments were repeated in buffer 
containing physiological (1.2 mM) calcium concentrations as in calcium-free 
buffer. Where many pancreatitis toxins lead to reduced cell death in the 
absence of calcium (Wen, Voronina et al. 2015), the dye loss induced by 
histones was as pronounced in the absence as in the presence of extracellular 
calcium (figure 5-5). Confirming the validity of the experimental setup, the only 
difference observed in the presence and absence of extracellular calcium 
was that there were no signal spikes in calcium-free media, consistent with an 
absence of calcium-induced calcium entry. Furthermore, the degree of dye 
loss as measured by the mean fura 2 signal loss at 360 nm was proportional to 
the histone concentration, mirroring the findings of the plate reader cell death 
experiment. 
To provide further support to the hypothesis that acinar cell permeabilization 
in response to histones is calcium-independent, the cell death experiment was 
repeated in normal buffer, low calcium buffer with and without calcium 
chelator and supra-maximal calcium concentrations (figure 5-5D). None of 
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these experimental conditions had any influence on acinar cell death in 
addition to histone concentration.  
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Figure 5-5 Representative trace of fura 2-related signal (340nm solid line, 380nm dashed line) in 
murine pancreatic acinar cell treated with 100µg/ml calf-thymus histones in the A) presence and 
B) absence of extracellular calcium (1.2mM and 0mM). C) Mean (+/- SEM) fura 2 – related signal 
following histone treatment in all observed cells. D) Maximal % PI uptake in histone-treated acinar 
cells in normal, calcium free and calcium excess containing buffers. Comparisons are by ANOVA, 
observations made in triplicate with n ≥ 4 experimental repeats. 
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5.8 Discussion 
Acute pancreatitis is characterised by high levels of extracellular histones in 
circulation. The levels tested in the in vitro set-up presented here are consistent 
with those found in experimental models of acute pancreatitis (Ou, Cheng et 
al. 2015), and also in human acute pancreatitis (Liu, Huang et al. 2017) or 
acute respiratory distress symdrome (Lv, Wen et al. 2017). Although levels in 
humans are reported closer to 50 µg/ml, concentrations in excess of 500 µg/ml 
have been measured in patients with severe disease. When applied directly 
to isolated pancreatic acinar cells, all of these concentrations can induce 
acinar cell necrosis. 
The data presented here support the hypothesis that positively charged 
histones interact with negatively charged proteins and/or phospholipids at 
the surface of cell membranes to facilitate their effects, demonstrated 
particularly well by reduced toxicity when reducing histone charge. Histones 
can, thus, be detoxified using negatively charged macromolecules or by 
reducing the net-positive charge of histones. This leads to the interesting 
hypothesis that the concentration of histones within the inflamed pancreas 
(see previous chapter) is facilitated by an exposure to the extracellular matrix 
and net-negatively charged proteoglycans such as heparin sulfate. It also 
allows the hypothesis that histones preferentially bind apoptotic cells exposing 
phosphatidyl sereine residues – the basis of Annexin V staining. Histones have 
been shown to expose phosphatidyl sereine on the surface of erythrocytes, 
for example, although it is unclear whether this is as a result of altered flippase 
activity or through apoptosis pathways (Semeraro, Ammollo et al. 2014). 
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Histones H3 and H4 are most frequently reported to increase in plasma of 
patients and experimental animals with acute inflammatory conditions and 
therapeutic administration of antibodies to these histones improve outcomes 
in these models (Liu, Ni et al. 2013; Kang, Zhang et al. 2014). Post-translational 
core histone modification, hyper-citrullination in particular, renders histones H3 
and H4 less susceptible to degradation and prevents chromatin packing by 
linker histones (Wang, Li et al. 2009). It is conceivable that specific histones 
exhibit greater toxicity, as suggested by the results here, but histones readily 
oligomerize in solution (Ramakrishnan 1997) and in the presence of a cellular 
milieu there will always be an ample supply of nuclear proteins, making true 
differential effects difficult to investigate in this setting. Nevertheless, the 
finding that of all the recombinant histones tested only H3 exhibited a dose-
dependence to its toxicity may suggest that while other subtypes contribute 
to toxicity, H3 is the necessary limiting factor. 
The experiments looking at calcium entry in response to histones demonstrate 
that histones increase acinar cell permeability to calcium. Furthermore, 
initially, this is associated with calcium spikes, typically observed in acinar cells 
as a result of calcium-induced calcium entry (Lur, Sherwood et al. 2011; Wen, 
Voronina et al. 2015). The amplitude of calcium spikes seen with Fluo-4, 
however, decrease with each spike, and the drop in baseline is suggestive of 
dye loss, a suspicion confirmed when looking at the calcium-independent 
wavelength of fura-2. Critically, removal of extracellular calcium abolishes 
calcium spikes, but does not protect acinar cells from necrotic cell death, 
indicating that acinar cell permeabilization is due to the creation of larger 
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pores that allows flux of ions and larger molecules, at least up to around 1 kDa, 
the molecular weight of propidium iodide. 
5.9 Summary 
Extracellular histones disrupt the plasmallemma of acinar cells in a dose and 
charge-dependent manner. This effect leads to permeabilization of the cells 
and rapid cell death in a calcium-independent process. 
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6 Pancreatic Micro-perfusion is Impaired During 
Acute Pancreatitis 
6.1 Visual abstract 
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6.2 Background 
The anatomy of the pancreas, including its blood supply, are very well 
described. However, there are significant anatomical differences between 
murine and human pancreata (Dolensek, Rupnik et al. 2015). Whereas in 
humans the pancreas is a clearly defined organ, fixed anatomically adjacent 
to the duodenum by its peritoneal covering, in mice and other quadruped 
mammals it is distributed in three major parts throughout the proximal small 
bowel mesentery (Liu, Xue et al. 2010). The arterial supply of the gland is highly 
variable in humans (Macchi, Picardi et al. 2017), with blood being supplied by 
three major vessels: the common hepatic artery, the splenic artery and the 
superior mesenteric artery (Bertelli, Di Gregorio et al. 1995; Bertelli, Di Gregorio 
et al. 1996; Bertelli, Di Gregorio et al. 1996; Bertelli, Di Gregorio et al. 1997; 
Bertelli, Di Gregorio et al. 1998). The blood supply to the head and body/tail 
of the pancreas is functionally distinct allowing surgical resection of part of the 
gland. There are no detailed studies of murine pancreatic blood supply, 
although it is macroscopically considered similar to that of the human 
pancreas (Dolensek, Rupnik et al. 2015). Microscopically, however, there are 
important differences between the murine and human pancreas. In humans, 
pancreatic islets are located within acinar lobules, and blood flows from the 
major arterioles to the islets in the first instance, before supplying the acinar 
cells via an insulo-acinar portal circulation (Murakami, Hitomi et al. 1997). In 
mice, islets are generally located between acinar lobules and blood from 
islets drains directly into the portal venous system (Murakami, Fujita et al. 1993). 
Critically, all venous blood from the pancreas has to pass via the portal vein 
through the liver before it enters the systemic circulation (see Chapter 3). 
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At rest, the pancreas receives approximately 1% of total cardiac output, and 
blood flow has been measured using a wide variety of different techniques 
ranging from plethysmography to microsphere studies (Lewis, Reber et al. 
1998), and more recently intra vital microscopy to evaluate capillary perfusion 
(Schmidt, Ebeling et al. 2002; Ryschich, Kerkadze et al. 2009). Early studies of 
pancreatic blood flow made use of large mammals (frequently dogs), due to 
the technical difficulties in attaching the sub-millimeter blood vessels found in 
rats and mice to recording instruments (Mandelbaum and Morgan 1969; 
Goodhead, Himal et al. 1970; Studley, Mathie et al. 1987) and relative 
familiarity with the canine pancreas following the work on insulin (Banting, Best 
et al. 1922). Recent studies of murine pancreatic blood flow concentrate on 
microcirculatory disorders (Chen, Sunamura et al. 2001), but as a technique 
neither intra-vital microscopy nor microbeads can provide useful information 
with regard to the medium vessel-level perfusion of the murine pancreas. 
Ischaemia-reperfusion injury is a concept with its origin in cardiac research, 
whereby reperfusion of cardiac tissue after a period of ischaemia induces 
further tissue injury secondary to radical oxygen species (ROS) generation 
(Donato, Evelson et al. 2017). Mitochondrial calcium concentration, the ability 
of mitochondria to generate an electrochemical gradient and dissipating 
that gradient through opening of a mitochondrial permeability transition pore 
(MPTP) are all factors that contribute to myocardial injury following ischaemia 
(Andrienko, Pasdois et al. 2017). Similarly, mitochondrial calcium, opening of 
the MPTP and mitochondrial ROS generation are all critical factors in acinar 
cell injury following non-primary ischaemic insults to the pancreas (Criddle, 
Gerasimenko et al. 2007; Mukherjee, Criddle et al. 2008; Booth, Murphy et al. 
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2011). One of the cardinal features of myocardial ischaemia-reperfusion 
injury, is that repeated episodes of sub-clinical ischaemia protect from a major 
future ischaemic event – so called ischaemic preconditioning (Donato, 
Evelson et al. 2017). Ischaemic preconditioning has been shown to reduce the 
severity of ischaemia/reperfusion-induced acute pancreatitis in rats, but more 
interestingly short periods of pancreatic ischaemia (clamping of the coeliac 
artery) has also been shown to be effective in reducing pancreatic injury and 
inflammation following cerulein-induced acute pancreatitis (Warzecha, 
Dembinski et al. 2005; Warzecha, Dembinski et al. 2007). This suggests either 
that the protective mechanisms involved in ischaemic preconditioning 
protect from a multitude of inflammatory conditions, or that ischaemia is a 
hallmark of acute pancreatitis, even if induced by cerulein. 
Abnormalities of blood flow, in particular capillary occlusion manifesting in a 
reduction in capillary density, have been observed during acute pancreatitis 
in a number of different experimental models (Nuutinen, Kivisaari et al. 1986; 
Plusczyk, Westermann et al. 1997), and similarly reduced pancreatic blood 
flow has been observed in patients with acute pancreatitis using cross 
sectional imaging (Delrue, Blanckaert et al. 2012; Watanabe, Tsuji et al. 2013; 
Yadav, Sharma et al. 2015). The aim of the following set of experiments was to 
develop experimental techniques to assess pancreatic blood flow in the same 
12 cerulein injection murine model used repeatedly thus far and to assess 
uniformity of blood flow within the inflamed pancreas at a whole-organ level. 
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6.3 Specific methods 
6.3.1 In vivo/in situ perfusion 
Two different perfusion methodologies were trialled: cardiac output-driven 
self-perfusion, and ex vivo pump perfusion. The principles of microsphere 
perfusion were similar to previously published methods (Deveci and Egginton 
1999) and following the principles set out by the Fluorescent Microsphere 
Resource Centre (University of Washington, Seattle, WA, USA; 
fmrc.pulmcc.washington.edu – accessed April 2015). For imaging in acute 
pancreatitis, perfusion was commenced one hour after the last cerulein 
injection in a 12-hourly injection model of cerulein acute pancreatitis (see 
common methods). 
For determination of whole-organ blood flow, CD1 Swiss-type mice had their 
left carotid arteries and left femoral arteries cannulated under terminal 
anaesthesia using a dissecting mircoscope. Carotid artery cannulae were 
advanced just beyond the thoracic inlet and secured using a bulldog clip. 
Arterial cannulae were locked with 200 IU unfractionated heparin. 140,000 
microspheres were injected via the carotid artery cannula in a slow bolus over 
60 seconds in 500 µl of PBS using a fixed-rate infusion pump, while 
simultaneously withdrawing blood from the femoral artery cannula. Animals 
were culled by anaesthetic overdose following the sampling process, and the 
pancreas, kidneys and lung were extracted. 36,000 Blue-green control 
microspheres were added to tissue and blood samples, which were then 
digested for 48 h in 2.3 M ethanolic KOH with 0.5% Tween 80 at 50 °C, vortexing 
at 24 and 48 h and sedimented at 2000 xG for 20 minutes. The sediment was 
then rinsed and re-centrifuged twice with 1% Triton X-100 prior to dissolution of 
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microspheres in 2-ethoxyethyl acetate in a fume cabinet. Samples were 
centrifuged again after 24 hours at 2000 xG for 20 minutes and fluorescence 
in the supernatant measured using a BMG POLARstar Omega Microplate 
Reader (Imgen Technologies, New York, USA). Microspheres are resistant to 
KOH digestion, but are readily dissolved by 2-ethoxyethyl acetate, allowing 
retrieval of microspheres from tissue with this digestion/sedimentation method, 
prior to releasing the pure fluochrome ready for measurement. Addition of 
control microspheres at the beginning of the digestion process allows for an 
estimate (and correction) of microspheres during the repeated 
wash/sedimentation steps. Fluorescence was. To count as a successful 
experiment, fluorescence in lung tissue should be low (indicating limited re-
circulation of microspheres) and difference in fluorescence between both 
kidneys should be less than 20% (indicated adequate mixing upon carotid 
injection). Fluorescence in the known volume of blood sampled over 60 
seconds from the femoral artery was used to calculate pancreatic blood flow 
as a ratio of fluorescence. 
For the imaging of regional pancreatic perfusion, CD-1 Swiss mice (Charles 
River, UK) were culled by overdose of anaesthesia, and their abdominal aorta 
quickly cannulated using a dissecting microscope on a heated table (Figure 
6-1). Upon cannulation, a bulldog clamp was applied across the aorta 
immediately proximal to the left renal artery and a second clamp to the 
thoracic aorta just above the diaphragm. The aorta was the perfused with 
0.9% Saline at a rate of 1 ml / min for 2 minutes, before 10-minute perfusion 
with a solution of 3% agarose (ultra-low gelling point) containing either 10% 
TRITC-dextran, 1 µm-diameter fluorescent microspheres, Gd(III)-based MRI 
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contrast agent (Magnavist) or FeO. This perfusion method resulted in near 
isolated pancreatic perfusion, as detailed in figure 6-2. Retrograde perfusion 
via the hepatic portal vein was also trialled (figure 6-3) as this is technically 
much more straight-forward, however this resulted in global perfusion of the 
small bowel mesentery. Immediately following cessation of perfusion, animal 
corpses were placed in a freezer at -4 °C to ensure gelling of intra-vascular 
agarose solution, similar to previously published methods (Dutly, Kugathasan 
et al. 2006). Whole pancreata, including proximal duodenum and spleen, 
were then extracted and imaged using either an IVIS Spectrum preclinical 
imaging system (Perkin Elmer, Waltham, MA, USA), or immobilised in a 10% 
agarose gel within a 7 ml Bijou tube, prior to imaging with a 9.4 T Bruker Biospec 
94/20 USR MRI machine (Bruker UK Ltd, Coventry, UK). Fluorescent images were 
collected using IVIS fluorescence unmixing settings to separate dye-specific 
and tissue background fluorescence. Intensity was measured using Image J 
1.51s for Mac (ImageJ 1.51s for Mac, NIH, USA).  
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Figure 6-1 Arterial perfusion set-up. Diagram of liver, pancreas, aorta, and vena cava, detailing the 
set-up for arterial pancreatic perfusion. The black arrow indicates placement of the perfusion 
cannula. The black parallel lines indicate Bulldog clamps. Picture insets (top to bottom): Bulldog 
clamp on supra-hepatic vena cava; in situ pancreas following perfusion with Methylene Blue; 
abdominal aorta (lefted by forcepts) next to abdominal vena cava. 
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Figure 6-2 Portal venous perfusion set-up. Diagram of liver, pancreas, aorta, portal vein and vena 
cava detailing the set-up for portal venous pancreatic perfusion. The black arrow indicates 
placement of the perfusion cannula. The black parallel lines indicate occlusive sutures. Picture 
insets (top to bottom): perfusion cannula sutured in place within portal vein; in situ pancreas and 
proximal small bowel following perfusion with Methylene Blue. 
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6.3.2 Reagents 
FluoSpheresTM fluorescent microparticles were purchased from ThermoFisher 
(Life Technologies LTD, Paisley, UK) in 1 and 10 µM diameters, conjugated to 
yellow/green (505/515), red (580/605) and blue/green (430/465) fluorescent 
dyes. PBS, agarose (ultra-low gelling point) and TRITC-dextran (average 
molecular weight 40 kDa) were purchased from Sigma (Sigma-Aldrich 
Company Ltd, Dorset, UK). Plastic tubing (external diameter 0.8 mm) for 
vascular cannulation, Gd(III)-based MRI contrast agent (Magnavist) and FeO 
nanoparticles were gifted by the Centre for Preclinical imaging at the 
University of Liverpool, UK. 
6.4 Total pancreatic blood flow is reduced in experimental acute 
pancreatitis 
Using cardiac output-driven self-perfusion with fluorescent microspheres, 
pancreatic blood flow could be estimated at around 1.2 ml/min/g tissue. This 
dropped to below 0.4 ml/min/g tissue in necrotising acute pancreatitis 
secondary to 12 hourly injections of cerulein (figure 6-4). Mixing of 
microspheres was deemed adequate in around 75% of experiments (a 
difference in fluorescence between left and right kidneys or <= 20%), but 
concurrent femoral artery sampling was only possible in around 50%, due to 
thrombosis of the first arterial cannula (despite heparinisation) in the time it 
took to cannulate the second artery. Given that standard poly-ethelene 
tubing was used in these experiments, it is likely that the more expensive 
heparin/EDTA impregnated vascular cannulae would result in more reliable 
experiments. 
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Where differences between fluorescence measured in the left and right 
kidney exceeded 20%, pancreatic fluorescence measurements were 
excluded from the blood flow analysis. It is notable that in all cases, 
fluorescence in the right kidney exceeded that of the left, suggesting a 
mechanism other than abnormal mixing, which would be expected to 
produce random differences in microsphere distribution.   
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Figure 6-3 A) Murine pancreatic blood flow estimated from pancreatic fluorescence following 
injection of 15µm fluorescenct microspheres via the carotid artery of CD1 Swiss mice under terminal 
anaesthesia. and concomitant fluorescence measurement of a known volume of femoral arterial 
blood collected over 60 seconds. B) Comparison of fluorescence in left and right kidneys as 
indication of even mixing of fluorescent particles. Solid oblique line indicates equivalent 
fluorescence; dotted line indicates 20% deviation from equivalence. Comparisons were made by 
Student’s t-test, with * denoting p<0.05 and ** p<0.01; n ≥ 12. 
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6.5 Cerulein-induced severe pancreatitis results in patchy organ 
perfusion and necrosis  
Following in situ arterial perfusion of mouse pancreata with 1 µm diameter 
fluorescent microspheres, duodenum, pancreas and spleen of experimental 
animals were resected en bloc and embedded in Bijou tubes within a 10% 
agarose gel. Imaging these tubes in an IVIS Spectrum epifluorescence 
chamber revealed whole-organ distribution of fluorescent particles. Figure 6-
4 demonstrates that overall pancreatic fluorescence intensity is lower in 
cerulein acute pancreatits compared to saline controls. Moreover, 
pancreata of AP animals exhibit patches of non-fluorescence (i.e.: hypo-
perfusion) not seen in that of saline controls. 
Histology reveals extensive necrosis in terminal lobules with intravascular 
thrombosis in lobular feeding vessels with near normal adjacent pancreatic 
tissue. This pattern of near total necrosis is only seen in association with terminal 
arterioles at the peripheries of the gland. Centrally, the more typical diffuse 
pattern of necrosis is observed. 
MRI imaging of the same pancreata reveal details of the vasculature down 
to a size of 0.1 mm. Similar to fluorescence and histological data, areas of 
near-normal appearance can be seen in cerulein AP pancreata, with 
patches of oedema (seen as bright white on Gd(III)-enhanced, T1-weighted 
images) associated with an obliteration of the normal microvascular pattern. 
Using FeO nanoparticles as contrast agent, major arteries traversing the 
pancreas can be seen as clearly patent in cerulein AP pancreata, with clear 
irregularities in some major vessels and patches of absent perfusion (figure 6-
5).  
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Figure 6-4 Fluorescence measurement of mouse pancreata perfused with fluorescent 
microspheres in cerulein-pancreatitis or saline controls. A) epifluorescence chamber image of 
microsphere-perfused murine pancreata suspended in agarose gel. B) whole-organ fluorescence 
following homogenisation and dye extraction from perfused pancreata. C) H&E-stained 
micrographs of pancreata from two distinct cerulein-treated mice at 100x and 400x magnification, 
demonstrating areas of significant necrosis (blue arrow) adjacent to near-normal tissue (yellow 
arrow) as well as thrombosis of a peripheral arteriole causing near total lobular necrosis (black 
arrow). Comparisons are by Student’s t-test, with * denoting p<0.05 and ** p<0.01; n ≥ 8. 
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Figure 6-5 MRI images of pancreata from mice treated with 12x hourly injections of 50µg/kg 
caerulen or saline controls. A&B) 3D reconstruction and volumetry of specimen, where yellow/red 
indicates areas of high perfusion in A, and B is colour-coded by organ (green = duodenum, yellow 
= pancreas and red = spleen). C) T1-weighted images with Gd(III)-based contrast medium and T2-
weighted images with FeO nanoparticles as contrast agent. Insets demonstrate vascular 
discontinuity and irregularity (red) and areas of hypoperfusion (blue). 
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6.6 Discussion 
Perfusion defects are a hallmark of acute pancreatitis, including 
hyperstimulation AP (Hackert, Pfeil et al. 2007). Using a number of different 
techniques, whole-organ perfusion was evaluated qualitatively and 
quantitatively in the murine pancreas using a severe cerulein hyperstimulation 
model of AP. This demonstrated a dramatic reduction of pancreatic blood 
flow immediately after induction of AP, as well as irregularities of medium-level 
vessels and patches of relative hypo-perfusion adjacent to near normal 
pancreatic tissue. The reperfusion that must follow this period of relative 
ischaemia was not investigated here, but presumably will contribute to the 
eventual area of tissue damage and necrosis, although the complex blood 
supply to the pancreas, through its multitude of inflow vessels with numerous 
collateral supply vessels, mean that confluent necrosis was only every 
observed in peripheral lobules supplied by single vessels, a feature which may 
limit added reperfusion injury by reducing the likelihood of complete 
ischaemia. 
Areas of necrosis always correlate with areas of extensive inflammatory 
infiltrate. The assumption had always been that DAMPs and chemokines 
released by injured and destroyed acinar cells recruit inflammatory cells, 
however it is possible that recruited inflammatory cells themselves contribute 
to intra-vascular thrombosis, thereby contributing to further ischaemia. Similar 
phenomena have been reported in AP (Ryschich, Kerkadze et al. 2009), in 
experimental venous thrombosis (Brill, Fuchs et al. 2012; Martinod, Demers et 
al. 2013) and arterial injury (Fuchs, Brill et al. 2010; Michels, Albanez et al. 2016), 
where histones or NETs interact with adjacent endothelium, thrombocytes and 
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neutrophils to induce and establish thrombus formation in inflamed tissue in 
otherwise healthy vasculature. Having demonstrated the presence and 
significance of extracellular histones in AP in previous chapters, one can 
postulate that the inflammatory infiltrate contributes to local ischaemia and, 
thereby, exacerbates tissue injury. In sepsis models it has been shown that such 
an effect can limit the spread of micro-organisms (McDonald, Urrutia et al. 
2012) and Group A Streptococcus has been found to express DNAse, allowing 
it to degrade NETs and produce rapidly spreading cellulitis and necrotizing 
fasciitis (Buchanan, Simpson et al. 2006). It is conceivable that a similar 
mechanism limits the injury caused by activated pancreatic proteases, 
explaining the lack of positive feedback and total necrosis seen in most 
patients with acute pancreatitis. This hypothesis would, however, also suggest 
that there is a protective function of immune-thrombosis in AP. 
Several ischaemic clinical conditions have been found to have a ‘golden 
window’ of therapy, where earlier re-perfusion reduces tissue injury and long-
term functional outcome. This is the case in ischaemic stroke (Osborn, 
LaMonte et al. 1999) and myocardial infarction (Heestermans, van 't Hof et al. 
2010), and the concept of a ‘golden hour’ of therapy has been more widely 
adopted in sepsis (Kumar, Roberts et al. 2006; Nugent and Coopersmith 2017). 
The only effective therapy in the management of acute pancreatitis, 
administration of intravenous fluid replacement, has similarly been shown, in 
a large international multicentre trial, to be more effective if given early 
(Singh, Gardner et al. 2017). Experimentally, however, limiting immune-
thrombosis prior to induction of acute pancreatitis has had mixed results in AP, 
sometimes exacerbating tissue injury (Ryschich, Kerkadze et al. 2009; 
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Warzecha, Dembinski et al. 2012). This leads to the possibility that there is 
indeed a ‘golden’ therapeutic window, but that unlike in other, purely 
ischaemic pathologies this window does not start with the onset of the 
disease. 
The perfusion techniques developed and described in this chapter are 
effective in measuring total pancreas blood flow in the mouse both at 
baseline and in acute pancreatitis, adding a further element of detail to the 
investigation of the disease and its therapies. The imaging of larger and 
medium sized vessels is of interest and has added to the understanding of the 
pathogenesis of the cerulein model, however it is likely too laborious, 
expensive and of limited value due to the resolution limitations of the MRI 
machine to be adopted more widely. Nevertheless, further development of 
this technique could allow in vivo imaging of pancreatic perfusion in mice, 
thereby introducing a further clinically relevant measure of pancreatic injury 
in pancreatitis with the potential to significantly reduce the number of 
experimental animals required for therapeutic studies. 
 
6.7 Summary 
Pancreatic blood flow is dramatically reduced in cerulein-induced acute 
pancreatitis and is associated with irregularities in major vessels as well as 
patches of significant hypo-perfusion throughout the gland.  
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7 Histones and NETosis as Therapeutic Target in 
Acute Pancreatitis 
7.1 Visual abstract 
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7.2 Background 
Perfusion defects or other detrimental effects on pancreatic microvasculature 
have been widely reported in experimental animals as well as human 
patients. In particular, constriction at the inter-lobular arteriolar sphincter 
(Zhou, Chen et al. 2002) and leukocyte adhesion at post-capillary venules 
(Schmidt, Ebeling et al. 2002; Hackert, Pfeil et al. 2007; Ryschich, Kerkadze et 
al. 2009) together result in a reduction in overall functional capillary density 
and reduced blood flow through capillary beds. Pancreatic perfusion defects 
can also be observed in patients, where they are either temporary or 
permanent, resulting in pancreatic necrosis (Tsuji, Yamamoto et al. 2007; 
Delrue, Blanckaert et al. 2012; Yadav, Sharma et al. 2015). Hepatic arterial 
perfusion has also been reported to increase in acute pancreatitis, without 
significant difference in portal blood flow, resulting in an overall increase in 
total hepatic blood flow seen in patients (Koyasu, Isoda et al. 2012) and 
experimental animals (Tutcu, Serter et al. 2010), possibly as a result of 
increased intra-pancreatic vascular resistance. 
Critically, defects in pancreatic perfusion can be modified and improved. 
Vasoactive substances such as endothelin-1 or platelet activating factor 
promote microcirculatory dysfunction, and their inhibition can normalise 
blood flow and reduce tissue necrosis (Foitzik, Hotz et al. 1999). Protease 
inhibition also improves blood flow (Keck, Friebe et al. 2005), although the 
mechanism could be inhibition of immune-thrombosis (Pfeiler, Massberg et al. 
2014). Anticoagulants such as heparin have also been used to improve 
pancreatic blood flow and reduce necrosis with some success, both in 
continuous regional arterial perfusion application (Ke, Ni et al. 2014) and as 
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pre-treatment (Ceranowicz, Dembinski et al. 2008; Koksoy, Yankol et al. 2013), 
although heparin has also been observed to abolish the beneficial effects of 
ischaemic preconditioning (Warzecha, Dembinski et al. 2012), suggesting that 
an initial period of transient ischaemia may be beneficial in acute 
pancreatitis. 
Heparin is a polysulfated carbohydrate present in mammalian gut (Li and 
Corey 2013) and its anti-coagulant activity depends on its interaction with 
antithrombin III, a charge mediated phenomenon dependent on multiple 
sulphate groups (Rao, Argyle et al. 2010). Heparins have well recognised anti-
inflammatory properties (Young 2008) and their high net-negative charge 
density make them likely competitive inhibitors of histone-induced toxicity. In 
light of the impairment in pancreatic microcirculation as well as histone 
toxicity described in previous chapters, the role of different heparin fractions 
in the treatment of cerulein-induced acute pancreatitis was evaluated. 
7.3 Specific methods 
7.3.1 Experimental models 
The 12 injection cerulein model was used throughout the experiments here 
described using the methods detailed in the general method section. All pre-
treatments were given one hour prior to the first cerulein injection and all 
treatments were administered 3 hours after induction of acute pancreatitis 
with the 4th cerulein injection. 
7.3.2 Reagents 
Unfractionated heparin (UFH) was purchased from Wockhardt (Wockhardt UK 
Limited, Wrexham, UK), Tinzaparin sodium (LMWH) from Sigma (Sigma-Aldrich 
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Company Ltd, Dorset, UK). O-desulfated heparin (ODS) – a heparin with very 
low anti-coagulant properties – was gifted from Cantex (Cantex 
Pharmaceuticals, Weston, FL, USA). Cl-amidine was from Calbiochem (Merck-
Millipore UK Ltd, Watford, UK) and GSK484 was from Cayman Chemicals 
(Cambridge Bioscience Ltd, Cambridge, UK). 
7.4 Heparins protect pancreatic acinar cells from histone-
induced injury 
Using a similar experimental set-up as in chapter 5, freshly isolated murine 
pancreatic acinar cells were seeded onto 96-well plates and Propidium 
Iodide-related fluorescence measured after 60-minute exposure to increasing 
concentrations of calf-thymus histones. In the absence of heparin, histones 
produced the familiar dose-dependent increase in PI-related fluorescence. 
Unfractionated heparin (UFH) was able to eliminate histone toxicity without 
exhibiting toxicity of its own. 2-0, 3-0 desulfated (ODS) heparin, a modified 
heparin with very low anticoagulant effect in vivo, was similarly able to reduce 
histone-induced toxicity, although did exhibit acinar cell toxicity of its own in 
the absence of histones (Figure 7-1).   
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Figure 7-1 Maximal recorded PI uptake in freshly isolated murine pancreatic acinar cells following 
administration of different doses of calf-thymus histones in the presence of two different types of 
heparin: unfractionated heparin and 2-0, 3-0-desulfated (low anticoagulant) heparin. 
Comparisons by ANOVA, where * denotes p<0.05, ** p<0.01, *** p<0.001 compared to control and 
# denotes p<0.05 compared to both control and other treatment group. Observations were made 
in triplicate with n ≥ 4 experimental repeats. 
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7.5 The effect of systemic heparin administration depends on the 
type of heparin used 
As the protective effect of heparin pre-treatment has already been 
investigated, these experiments focus on the potential utility of heparin as a 
therapy. Therefore, heparin was administered in the familiar 12 injection model 
of cerulein pancreatitis together with the 4th injection of cerulein – i.e.: 3 hours 
after induction of pancreatitis. Three different types of heparin were 
investigated: ODS heparin, UFH and tinzaparin, a type of low molecular weight 
heparin (LMWH). The common dose of 25 mg/kg has previously been used in 
the treatment of other inflammatory conditions in murine models (Griffin, 
Fischer et al. 2014). Figure 7-2 details the therapeutic effects of all three 
heparins as measured by serum biochemistry, organ protein activity and 
blinded histology. None of the parameters investigated showed any 
improvement. In fact, ODS heparin appeared to significantly exacerbate the 
inflammatory response, producing a statistically significant increase in 
amylase and IL-6 levels as well as pancreatic and lung myeloperoxidase 
activity. ODS heparin similarly increased inflammation and necrosis scores, 
however these differences did not reach statistical significance as the 
untreated group was already close to the maximal achievable score of 4 
points. ODS heparin further led to a statistical and clinically significant 
difference in pro-inflammatory markers, as well as the only mortality observed 
by the author in any cerulein-pancreatitis experiments. 
  
Histones and NETosis as Therapeutic Target in Acute Pancreatitis 
Peter Szatmary  February 2019 137 
  
Figure 7-2 Plasma amylase and IL-6 concentration, pancreatic trypsin and pancreatic and lung 
myeloperoxidase activity as well as blinded histopathological assessment of the pancreas 
(oedema, infiltration and necrosis) in experimental acute pancreatitis induced by 12x hourly i.p. 
injections of 50µg/kg cerulein or saline controls. Therapeutic groups all cerulein pancreatitis with 
three different types of heparin (UFH – 5000 IU/kg, ODS heparin – 25 mg/kg and LMWH – Tinzaparin 
25 mg/kg). All comparisons by ANOVA, where * denotes a difference of p<0.05 to cerulein; n ≥ 6. 
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To investigate this effect further, a lower dose of ODS heparin (10 mg/kg) was 
tried and the effects on systemic histone release and hepatic injury was 
measured. Figure 7-3 details the results of these experiments and shows that 
the lower dose of ODS heparin is not as toxic as the higher dose (but still fails 
to improve any of the measured parameters of pancreatic injury). Notably, as 
well as increasing pro-inflammatory mediators of pancreatitis ODS heparin 
increases levels of circulating histone H3 nearly 3-fold. Similarly, high 
concentrations of circulating histone H3 have been associated with organ 
dysfunction and lethal microvascular thromboses, potentially explaining the 
observed mortality.  
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Figure 7-3 Plasma amylase, IL-6, histone H3 and ALT concentration, pancreatic and lung 
myeloperoxidase activity as well as pancreatic trypsin activity in experimental acute pancreatitis 
induced by 12x hourly i.p. injections of 50µg/kg cerulein or saline controls. Therapeutic groups all 
cerulein pancreatitis with low (10 mg/kg) and high (25 mg/kg) doses of the non-anticoagulant ODS 
heparin. All comparisons by ANOVA, where * denotes a difference of p<0.05 to control and # 
denotes a difference of p<0.05 to cerulein; n ≥ 6. 
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7.6 Heparins inhibit the degradation of histone H3 in mouse 
plasma 
 
Histone H3 is rapidly degraded in plasma by the serine protease factor VII-
activating protease (FASP). To investigate the kinetics of histone degradation 
(and thereby detoxification), recombinant histone H3 was spiked into murine 
plasma at room temperature and incubated for several minutes, hours and 
overnight, with and without the addition of heparin, At the end of the 
respective incubation period, the reaction was stopped by heating the 
solution to above 60 degrees Centigrade and Western blot analysis was 
undertaken. 
Figure 7-4 demonstrates how histone degradation is complete in murine 
plasma at room temperature in under 10 minutes. Addition of heparin 
effectively inhibited histone degradation. Although both UFH and ODS 
heparin inhibited histone degradation, ODS heparin did this more effectively, 
an effect most evident during the overnight incubation.  
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Figure 7-4 Western blot of recombinant histone H3 incubated at room temperature in pooled 
plasma (C57Bl6/J) and treated with unfractionated (UFH) or non-anticoagulant ODS heparin; n = 
3 experimental repeats. 
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7.7 The effect of systemic heparin administration is dependent on 
the severity of experimental acute pancreatitis 
To investigate whether ODS heparin could similarly exacerbate a milder form 
of experimental acute pancreatitis, the experiments were repeated using the 
higher dose (25 mg/kg) of ODS heparin in a 4-cerulein injection model. Figure 
7-5 details the standard biochemical and histological parameters. There were 
no differences observed in any of the measured parameters, including 
plasma amylase, pancreatic trypsin or myeloperoxidase activity, lung 
myeloperoxidase activity and blinded histopathological assessment of 
pancreatic oedema, infiltration and necrosis.  
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Figure 7-5 Plasma amylase concentration, pancreatic trypsin and pancreatic and lung 
myeloperoxidase activity as well as blinded histopathological assessment of the pancreas 
(oedema, infiltration and necrosis) in experimental acute pancreatitis induced by 4x hourly i.p. 
injections of 50µg/kg cerulein or saline controls. Therapeutic group cerulein pancreatitis with non-
anticoagulant ODS heparin (25 mg/kg). All comparisons by ANOVA; n ≥ 6. 
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7.8 Pre-treatment with an inhibitor of NETosis ameliorates 
experimental acute pancreatitis 
Histone H3 has already been identified as a critical mediator of acute 
pancreatitis by others and in earlier chapters of this book. Moreover, necrotic 
acinar cells do not appear to be the primary source of histones in circulation. 
While it is possible that hepatocyte necrosis contributes to histone release, it is 
also likely that neutrophil extracellular traps form in hepatic sinusoids as 
observed during sepsis (McDonald, Urrutia et al. 2012; Tanaka, Koike et al. 
2014), and thus contribute to histones measured in the post-hepatic 
circulation. Therefore, inhibition of NETosis using established and novel 
inhibitors of PAD4 as pre-treatment should ameliorate acute pancreatitis. The 
two NETosis-inhibitors tested were Cl-amidine and GSK-484. 
Cl-amidine is an irreversible inhibitor of PAD4, with a preference for the Ca2+-
bound form of the enzyme (Luo, Arita et al. 2006), whereas GSK-484 was 
designed to bind reversibly to the low-calcium isoform (Lewis, Liddle et al. 
2015). Both effectively inhibit NET-formation in vitro. Pre-treatment was chosen, 
as this should yield the maximally observable benefit. Given the reversible 
nature of its binding, GSK-484 was given as a split dose and re-administered 4 
hours after induction of acute pancreatitis. 
Figure 7-6 details the effects of PAD4 inhibition in acute pancreatitis. Trypsin 
activity, pancreatic and lung myeloperoxidase activity were all improved 
following administration of Cl-amidine, as were histological assessment of 
pancreatic oedema, infiltration and necrosis. This coincided with a reduction 
in plasma histone H3 levels. GSK-484 did improve histopathological 
parameters, although this did not reach statistical significance. Pancreas and 
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lung myeloperoxidase activity, amylase levels and trypsin activity were 
unaffected by GSK-484.  
Histones and NETosis as Therapeutic Target in Acute Pancreatitis 
Peter Szatmary  February 2019 146 
  
Figure 7-6 Plasma amylase and histone H3 concentrations, pancreatic trypsin and pancreatic and 
lung myeloperoxidase activity as well as blinded histopathological assessment of the pancreas 
(oedema, infiltration and necrosis) in experimental acute pancreatitis induced by 12x hourly i.p. 
injections of 50µg/kg cerulein or saline controls. Therapeutic groups all cerulein pancreatitis, pre-
treated with the PAD-4 inhibitors GSK-484 (1 or 10 mg/kg) and Cl-amidine (40 mg/kg). All 
comparisons by ANOVA, where * denotes a difference of p<0.05 to saline and # denotes a 
difference of p<0.05 to cerulein; n ≥ 6. 
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7.9 Discussion 
Circulating histones are critical to the pathogenesis in acute pancreatitis, as 
detailed in earlier chapters. Histone toxicity depends on the electrostatic 
interaction between positively charged histone molecules and negatively 
charge residues of the plasma membrane. It therefore stands to reason that 
molecules with a high negative charge density, such as heparin, can detoxify 
histones. In vitro data presented here supports this hypothesis, consistent with 
data presented in earlier chapters and with published literature (Kleine, Lewis 
et al. 1997; Szatmary, Liu et al. 2017). In vivo, however, this finding is not 
reproduced using the 12 injection cerulein model. This is contrary to literature 
suggesting UFH (Ceranowicz, Dembinski et al. 2008) or LMWH (Koksoy, Yankol 
et al. 2013) are both protective in cerulein-induced pancreatitis. One possible 
explanation is the timing of therapy, heparin is often administered prior to 
induction of acute pancreatitis in studies reporting therapeutic success, or 
type of heparin used. Different heparin fractions can lead to markedly 
different clinical outcomes, as evidenced by the data using ODS heparin, so 
it is not reasonable to deduce a response to tinzaparin from other studies using 
enoxaparin, for example. Using either UFH or tinzaparin as therapy (3 hours 
after induction of acute pancreatitis), no therapeutic benefit was seen, and 
no bleeding or other complications observed. Using the low-anticoagulant 
ODS heparin, however, a marked exacerbation of all parameters could be 
observed, as well as mortality not usually associated with the cerulein model. 
This phenomenon requires further explanation. 
Firstly, studies using the same ODS heparin obtained from the same source at 
the same dose have reported inhibition of neutrophil elastase and HMGB1 in 
Histones and NETosis as Therapeutic Target in Acute Pancreatitis 
Peter Szatmary  February 2019 148 
a model of airway inflammation (Griffin, Fischer et al. 2014), both effects 
should ameliorate acute pancreatitis, not exacerbate it. Secondly, although 
there was some toxicity observed in in vitro studies, no exacerbation of acute 
pancreatitis was seen in the milder 4 injection model, making substance 
toxicity an unlikely explanation for this phenomenon. The finding that ODS 
heparin effectively inhibits histone degradation could be a partial 
explanation. High concentrations of histones and other positively charged 
DAMPs such as HMGB1 in the portal circulation could induce a more severe 
inflammatory response in the liver, and histones in systemic circulation can 
lead to distal organ dysfunction and worsening pancreas injury as detailed in 
earlier chapters. UFH, however, also significantly delays histone H3 
breakdown, and a similar exacerbation of acute pancreatitis is not observed 
with UFH. The main difference between ODS heparin and UFH, apart from the 
relative homogeneity of molecular weight in ODS heparin, is the ability to bind 
antithrombin (Chen, Lin et al. 2017), which itself has been observed to 
correlate inversely with histone H3 in sepsis patients (Wildhagen, Wiewel et al. 
2015). Therefore, there could well be a confounding effect relating to the 
specific binding characteristics of ODS heparin, which are not immediately 
apparent from the data presented here. 
With respect to the anticoagulant properties of heparin, something frequently 
cited as a draw-back when using heparin therapeutically, no bleeding 
complications were observed during any of the experiments above. Indeed, 
the role of the coagulation cascade in this context warrants further detailed 
investigation. Extracellular histones have been observed to interfere with 
heparins anticoagulant activity (Longstaff, Hogwood et al. 2016), and an 
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initial period of hypoperfusion and microthrombosis has been reported as 
beneficial in the context of acute pancreatitis (Ryschich, Kerkadze et al. 2009; 
Warzecha, Dembinski et al. 2012). 
Data on PAD4 inhibition is a little easier to interpret. Cl-amidine effectively 
reduces extracellular histone levels in acute pancreatitis, together with all 
other measured markers of inflammation and pancreatic injury. This suggests 
that the release of histones into systemic circulation is PAD4 dependent and 
identifies innate immune cells as likely candidates, although it cannot be ruled 
out that PAD4 inhibition reduces intra-pancreatic injury or affects hepatocytes 
in a manner that produces the observed experimental results. The finding that 
GSK-484 is less effective than Cl-amidine has a number of possible 
explanations. Firstly, GSK-484 has a much lower solubility in water than Cl-
amidine and although it does dissolve in aqueous buffer it has the tendency 
to precipitate, making the effective circulating dose in animals more difficult 
to predict. Secondly, the fact that GSK-484 binds PAD4 reversibly means that 
the dosing regimen chosen (2 doses in 12 hours) may still have resulted in lower 
effective PAD4 inhibition in the in vivo setting. Finally, the fact that GSK-484 has 
a binding preference for the Ca2+-free form of PAD4, whereas Cl-amidine has 
a preference for the high-Ca2+-bound form is a further possible reason why its 
therapeutic effects are significantly more pronounced. Its effect on the cell-
cycle renders Cl-amidine unsuitable for human use, however the data 
presented here indicates that the NETosis pathway has promise and warrants 
further investigation and development. 
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7.10 Summary 
Inhibitors of NETosis ameliorate experimental acute pancreatitis when 
administered as prophylaxis. Using heparins as systemic therapy in cerulein-
induced pancreatitis, despite their ability to bind extracellular histones 
effectively, was found to be ineffective and potentially detrimental.  
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8 Overview 
The work presented here describes early acute pancreatitis as an 
inflammatory syndrome, mediated by myeloid cell populations and resulting 
in systemic inflammation and organ dysfunction. Chapter 3 documents the 
recruitment of neutrophils and inflammatory monocytes to the injured 
pancreas by chemokines, as well as the negative feedback systems that limit 
excessive cellular infiltration. Reduced tissue injury following reduction in 
myeloid infiltration has been well documented, but data in chapter 3 
demonstrate the differential effects of neutrophils and inflammatory 
monocytes on lung and pancreatic injury. Chapter 4 identifies extracellular 
histones as critical mediators of pancreatic and systemic injury and the liver 
as the main source of histones in the systemic circulation. Chapter 5 describes 
the molecular mechanisms by which histones interact with pancreatic acinar 
cell membranes, thereby laying the foundations for the genesis of novel 
therapies. Chapter 6 details the development of novel methods for the 
investigation of impaired microvascular blood flow in experimental acute 
pancreatitis, which is a hallmark of immunothrombosis and one of the putative 
indirect mechanisms of histone-mediated pancreatic injury. Finally, chapter 7 
investigates the roles of inhibiting nucleosome release in vivo and binding 
circulating histones using a novel non-anticoagulant heparin as therapeutic 
agent in the treatment of acute pancreatitis. In this final therapeutic chapter, 
great care was taken not to replicate well established experimental therapies, 
so the use of anti-histone antibodies and heparin as a prophylactic agent was 
avoided. 
Overview 
Peter Szatmary  February 2019 152 
The findings of the above chapters and how they advance our current 
understanding of the pathophysiology of early acute pancreatitis is discussed 
in the subsequent three sections.  
8.1 Response to Pancreatic Insult 
Investigating the cellular events that occur early (i.e. within minutes to hours) 
of pancreatic insult necessitates use of experimental models, as patients with 
acute pancreatitis often present 24-48 hours after the onset of pain (Jin, 
Lacson et al. 2018). As mentioned earlier, injection of bile into the pancreatic 
duct of dogs was the first description of an experimental model of acute 
pancreatitis, and the first documented case of acute pancreatitis of known 
aetiology in humans by Eugene Opie in 1901 (Lerch, Weidenbach et al. 1994). 
For the work presented here, however, the hyperstimulation model was 
chosen rather than the bile-acid model as one that is most reproducible, 
reliable, best reflects the early events of acute pancreatitis and leads to 
systemic inflammation entirely resulting from the injury to the pancreas 
(Gorelick and Lerch 2017). While it is one of the commonest experimental 
models in use today, it is also one of the least relevant models to human 
disease. Nevertheless, early immunological mechanisms could not be 
investigated using a model that requires surgery, which in itself induces 
inflammation and alters levels of many of the cytokines measured in chapter 
3 – inflammatory sequence (Fu, Norman et al. 1996). Moreover, the ability to 
investigate therapies early following initiation of pancreatitis reliably is an 
important advantage. Repeated injections of cerulein over several days 
produces acinar cell loss and pancreatic fibrosis as well as the exocrine and 
endocrine insufficiency seen in human chronic pancreatitis (Goto, Nakano et 
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al. 1995; Van Laethem, Robberecht et al. 1996; Murayama, Barent et al. 1999), 
or indeed recurrent acute pancreatitis, suggesting that the interplay of 
cerulein-induced pancreatic injury and the immune system has significant 
similarities with human disease. 
The mouse model is also critical in allowing investigation of the extra-
pancreatic immunological effects of acute pancreatitis. Chapter 3 details 
components of the inflammatory cascade that have not been described in 
this form to date. For example, chemokine expression and release is well 
described in acinar cells in acute pancreatitis (Saluja and Steer 1999; Sun and 
Bhatia 2007), however the description of the spacio-temporal relationship is 
novel. Data in chapter 3 detail chemokine release, leading to amplification 
of cytokines by the liver and influx of pro-inflammatory monocytes into the 
pancreas (with a concomitant reduction of monocytes in circulation). The 
cytokine feedback mechanisms described using cell depletion models had 
also not been described in vivo in acute pancreatitis. Specific depletion of 
circulating leukocytes is associated with an increase in specific chemokines 
(i.e. monocytes – MCP-1; neutrophils – KC), without an effect on more 
generalised inflammatory cytokines (i.e. IL-6, TNFa). Such location-specific 
mechanisms provide some indication why systemically administered 
chemokine inhibitors may have limited effects. 
The finding that depletion of monocytes appears to limit pancreatic injury, 
whereas neutrophil depletion limits lung inflammation is in keeping with 
previous literature, where inhibition of neutrophil elastase using sivelestat 
protects from lung injury without protection from pancreatic injury (Guo, 
Yamaguchi et al. 1995; Imamura, Mikami et al. 1998; Wang, Tang et al. 2012) 
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and monocytes selectively induce pancreatic injury via TNFa (Perides, Weiss 
et al. 2011). This highlights the importance of being aware of differential 
effects on similar myeloid cell populations when performing depletion studies, 
as off-target effects can confound experimental results. 
 
8.2 Systemic Mediators of Pancreatic Inflammatory Syndrome 
Acute pancreatitis is recognised as a mild, self-limiting condition in the majority 
of cases. Patients who suffer mortality do so as a result of catastrophic failure 
of multiple organ systems, driven by inflammatory mediators. This dichotomy 
led to the 1992 Atlanta consensus definition of mild and severe acute 
pancreatitis (Bradley 1993) (revised to include a ‘moderate’ category in 2012 
(Banks, Bollen et al. 2013)) and depends on the presence or absence of 
systemic disease (organ failure) as well as local complications (pancreatic 
necrosis and/or fluid collections). Being outcome classifications, patients in 
the respective categories also exhibit differences in other outcomes such as 
mortality, length of stay or the need for invasive procedures in the 
management of their disease. 
A large number of physiological and biochemical scoring systems have been 
developed allowing prediction of these outcomes in retrospective datasets, 
validating them prospectively with relative accuracy (Khanna, Meher et al. 
2013; Vasudevan, Goswami et al. 2018). Chapter 4 demonstrates how these 
predictors can be supplemented by the measurement of circulating 
nucleosomes or histones, thereby linking the activity of the innate immune 
system to the severity of pancreatitis mechanistically. Data presented in 
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chapter 4 further demonstrate how histone are not only released into the 
systemic circulation in acute pancreatitis but concentrate within the inflamed 
pancreas to further exacerbate injury. This dual role of marker of injury severity 
as well as contributor to further injury (including pancreatic, pulmonary, 
cardiac and renal (Abrams, Zhang et al. 2013; Bosmann, Grailer et al. 2013; 
Alhamdi, Zi et al. 2016; Kawai, Kotani et al. 2016)) may explain why histone 
measurement is at least as good if not better than other markers and can be 
measured at an earlier time point. 
These findings also provide some insight into the genesis of organ failure in the 
pancreatic inflammatory syndrome. Organ failure is rarely a global 
phenomenon in acute pancreatitis. The lung is generally the first or only organ 
to fail (Szatmary, IAP Presentation 2015) and is an independent predictor or 
mortality (Skouras, Hayes et al. 2014; Parniczky, Kui et al. 2016). While the liver 
can be seen as the main regulator of local pancreatic versus systemic injury, 
as indicated in chapter 3 and supported by other pre-clinical data (Gloor, 
Blinman et al. 2000; Folch-Puy 2007; Wang, Liu et al. 2015), the lung can be 
injured directly through circulating toxins as well as activated pancreatic 
proteases bypassing the liver through the thoracic duct in mesenteric lymph 
(Mittal, Phillips et al. 2009). 
Pancreatic necrosis was deemed sufficient to categorize acute pancreatitis 
as severe in 1992 (Bradley 1993). However, a realisation that necrosis in the 
absence of organ failure probably did not by itself contribute to a significant 
increase in mortality (Ashley, Perez et al. 2001) led to a revision of the original 
Atlanta Classification (Banks, Bollen et al. 2013) which downgraded the 
significance of pancreatic necrosis in the absence of organ failure and led to 
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the development of a rival classification system, which eliminated the 
inclusion of pancreatic necrosis as a determinant of severity entirely (Dellinger, 
Forsmark et al. 2012). Data presented in chapter 4 support the argument that 
pancreatic necrosis contributes to organ failure via the pancreatico-hepatic 
axis, allowing the hypothesis that pancreatic necrosis leads to mortality via 
organ failure, rather than some intrinsic mechanism. In this model, added 
mortality seen from infected necrosis (Besselink, van Santvoort et al. 2009; 
Werge, Novovic et al. 2016) can be in part explained by the increased 
inflammatory stimulus to the liver and the subsequent increase of systemic 
inflammation observed in animal models when adding LPS to sterile stimuli 
(Colletti and Green 2001; Gray, Simovic et al. 2003). This conceptual model of 
liver-derived systemic inflammation resulting from a co-stimulus of bacterial 
fragments and DAMPs/cytokines provides a putative explanation why 
pancreatic necrosis does not lead to organ failure in all cases, and why 
infected necrosis (Dellinger, Forsmark et al. 2012) and gut barrier dysfunction 
(Koh, Jeon et al. 2012; Schietroma, Pessia et al. 2016) exacerbates organ 
failure and mortality in patients with acute pancreatitis. 
8.3 Challenges in the Treatment of Acute Pancreatitis 
There are a number of practical and pathophysiological challenges in the 
development of novel therapies for acute pancreatitis. Fundamentally, 
despite being one of the commonest GI-related reasons for hospital admission 
in the West, standard trial endpoints such mortality or organ failure are too 
uncommon to adequately power clinical trials, a problem highlighted in a 
recent Cochrane review (Moggia, Koti et al. 2017). For example, in an 8-year 
national dataset study from the US over 69 million hospital discharges were 
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recorded. This included nearly 1 million patients with acute respiratory distress 
syndrome, only 32,000 of which were due to acute pancreatitis (Eworuke, 
Major et al. 2018). That equates to approximately 4000 cases of pancreatitis-
related respiratory distress syndrome in the entire US. Problems to adequately 
power clinical trials in pancreatitis make collaborative efforts between 
institutions essential. Nevertheless, even large, multinational trials can fail if 
powered on the wrong outcomes. A prime example of this are the lexipafant 
trials – a series of randomised controlled trials of a platelet activating factor 
inhibitor (Kingsnorth, Galloway et al. 1995; McKay, Curran et al. 1997; Wyncoll 
and Beale 1998; Johnson, Kingsnorth et al. 2001), which were powered on 
crude endpoints such as mortality and reduction in proportion of 
complications and included patients up to 72 after onset of the disease and 
often with established organ failure. The potential of cytokine inhibition lies in 
prevention of organ failure and, based on data presented in chapter 3, is 
unlikely to affect pancreatic complications as the cellular inflammatory 
response in the pancreas is evident by 12 hours after disease onset. 
One potential solution to the above problem, is introducing healthcare 
systems akin to those seen in acute ischaemic events such as myocardial 
infarction or stroke or indeed sepsis, where early diagnosis and urgent 
treatment within an hour of onset of symptoms has demonstrable advantages 
for outcome (Heestermans, van 't Hof et al. 2010; Nugent and Coopersmith 
2017). A further solution to the problem of adequate study power lies in 
selection of robust, continuous outcomes. 
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8.3.1 Disease activity index 
A current development in the management of acute pancreatitis is the 
measurement of ‘disease activity’ on a daily basis using a selection of largely 
clinical parameters to produce a compound activity score. While such a 
score undoubtedly is of clinical value in its own right, developing such an index 
would also benefit the development of novel therapeutics as improvements 
in the continuous activity score variable could be used to power trials. The 
current leading proponents of a daily disease severity index have published 
their proposed criteria as the Southern California Pancreas Study Group(Wu, 
Batech et al. 2017). Their five criteria are any organ failure (as defined by 2 or 
more points on the Marshall score(Marshall, Cook et al. 1995)), SIRS 
criteria(Banks, Bollen et al. 2013), abdominal pain, morphine dose in mg and 
whether or not solid oral diet is tolerated. Experimental data presented in 
chapter 3 demonstrates how initial pancreatic injury leads to the release of 
chemokines that recruit inflammatory cells from the bone marrow into the 
circulation (one of the SIRS criteria) and to the pancreas to contribute to 
inflammation and pain. Cytokine release is amplified by the liver and 
contributes to the haemodynamic and pyrogenic effects of systemic 
inflammation (Yu, Wei et al. 2017). Moreover, IL-1b and TNFa remain elevated 
24 hours after induction of pancreatitis and are potent pyrogens and 
contribute to anorexia of disease (Cannon and Kluger 1983; Zampronio, Melo 
et al. 1994; Luheshi, Bluthe et al. 2000; Lawrence and Rothwell 2001), 
supporting the use of SIRS criteria (tachycardia, pyrexia/hypothermia, 
leucocytosis/leukopoenia, tachypnoea) and return to oral diet as activity 
indicators. 
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Data presented in chapters 3 and 4 could aid the development of a 
biochemical activity score, adding to the understanding of the early cellular 
and molecular immunological events in the pathogenesis of acute 
pancreatitis. Indeed many groups have reported on the significance of 
number and ratios between certain immune cell populations and outcomes 
in acute pancreatitis (Shrivastava and Bhatia 2010; Zhang, Wu et al. 2016; 
Jeon and Park 2017) as well as the role of cytokines as disease predictors 
(Nieminen, Maksimow et al. 2014). Histone release detailed in chapter 4, 
together with the release of other pro-inflammatory mediators including 
HMGB1 (Kang, Lotze et al. 2014; Kang, Zhang et al. 2014; Kawai, Kotani et al. 
2016) contributes to organ failure in a manner that closely mimics the 
sequence of organ failure observed in human acute pancreatitis (ie lung 
before other organs). Therefore, in addition to the clinical manifestations used 
for the disease activity index one could propose a panel of molecular 
parameters to supplement the daily activity index including cytokines (TNFa, 
IL-6, IL1b), histone H3 (and HMGB1) and monocyte/neutrophil numbers to 
establish a cellular and molecular activity index to objectively probe the 
pathophysiology and help target therapies to individual patients at the 
correct time. 
8.3.2 Immunothrombosis and drug delivery 
Finally, delivering a drug therapy to the injured pancreas is itself fraught with 
difficulty. For example, inhibitors of pancreatic proteases have been 
developed and are used in clinical practice, predominantly in Japan, given 
intra-venously or as continuous regional arterial infusion alone and in 
conjunction with antibiotics with mixed effects. Despite promise in some 
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observational studies, larger cohort studies and meta-analyses have shown 
no benefit (Hamada, Yasunaga et al. 2013; Horibe, Egi et al. 2015; Horibe, 
Sasaki et al. 2017), and use is not recommended in the latest version of the 
Japanese guidelines for the management of acute pancreatitis (Yokoe, 
Takada et al. 2015). Experimentally, gabexate mesilate and nafamostat 
mesilate (two sereine protease inhibitors in clinical use) infusions improved 
pancreatic blood flow and increased capillary density in rats with severe 
acute pancreatitis (Keck, Friebe et al. 2005). This effect, however, has only 
been demonstrated in concomitant- or pre-treatment. Leukocyte 
extracellular traps have clot generating and stabilising abilities that make lysis 
of established clots difficult in the absence of DNAse (Longstaff, Varju et al. 
2013; Gould, Vu et al. 2015; Varju, Longstaff et al. 2015; Szatmary, Huang et al. 
2018). This ‘immunothrombosis’ may account for the differential effects seen 
in protease inhibitor trials. Data in chapter 6 demonstrates the patchy 
perfusion seen in acute pancreatitis, presumably limiting delivery of 
therapeutics to areas where they could provide the greatest benefit. Chapter 
7 demonstrates the lack of efficacy in treatment – a mere 3 hours after 
initiation of pancreatitis – of a therapy (heparin) that shows promise when 
administered prophylactically. Furthermore, while heparin therapy was not 
effective when administered systemically, possibly in part due to its stabilising 
effects on circulating histone H3, its ability to bind and reduce injury caused 
by circulating histones is well demonstrated in vitro. Exploring the use of 
heparin-primed absorption columns in a set-up similar to continuous veno-
venous haemofiltration may prove beneficial in early acute pancreatitis, 
where short-term haemofiltration has already demonstrated a reduction of 
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organ failure and mortality in patients with severe acute pancreatitis (Guo, 
Huang et al. 2014; Guo, Suo et al. 2016; Xu, Cui et al. 2017). 
Extrapolating from data presented here on the cellular inflammatory 
sequence and blood flow leads to a view of pancreatitis where injury attracts 
innate immune cells that enter the pancreas to contain injury by restricting 
blood supply to the injured area. This then causes further ischaemic injury to 
adjacent cells. If the volume of pancreas affected is small, resolution of tissue 
damage occurs. If, however, the segment of under-perfused pancreas is too 
extensive, the ensuing tissue injury can no longer be contained and the 
ensuing portal DAMPs induce the liver to augment the systemic inflammatory 
response. Organ failure and death results. This model is evidently conjecture, 
however based on data presented in the preceding chapters as well as 
published literature. To test this hypothesis methods of measuring tissue injury 
and blood flow in vivo and on a whole organ level need to be developed. 
The MRI-based techniques described in chapter 6 do not provide adequate 
contrast to image in vivo at present, and although detecting perfusion 
defects is more successful in patients (Yadav, Sharma et al. 2015), linking this 
finding to portal blood samples is impractical. Nevertheless, if found to broadly 
hold true, it would mean there are at least two distinct phases of the cellular 
inflammatory response, firstly containment of injury and secondly control and 
resolution of cellular damage. This may provide an indication why pancreas-
specific therapies have thus far proven difficult to develop and calls for 
regimen of agents administered at specific stages of the disease to achieve 
specific goals.  
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8.3.3 Portal sepsis and the liver as gatekeeper of systemic inflammation 
The interaction between the liver, lung and pancreas during acute 
pancreatitis is under investigated. Chapters 3 and 4 detail how the liver is the 
source of many cytokines in circulation, in agreement with the literature 
(Gloor, Todd et al. 1998; Gloor, Blinman et al. 2000). Data in these chapters, 
however, analyses portal blood in acute pancreatitis, which may represent 
changes in the proximal gastro-intestinal tract rather than just pancreatic 
injury. In an elegant study Hoyos et al. demonstrate that systemic 
inflammation, cytokine levels and lung injury secondary to acute pancreatitis 
was reduced by creation of a porto-caval shunt, but not a meso-caval 
shunt(Hoyos, Granell et al. 2005). This indicates not only that the liver is the 
source of the measured cytokines (TNFa, IL-1b and heat shock protein 72), but 
that release was induced only by blood from the pancreas and not the 
proximal gastro-intestinal tract. Nevertheless, intestinal barrier dysfunction and 
endotoxaemia is a feature of clinical pancreatitis (Schietroma, Pessia et al. 
2016; Shen, Li et al. 2017) and occurs maximally between 24 and 48h after 
disease onset in a rat model of acute pancreatitis (Liang, Chen et al. 2014), a 
similar time-course to the peak histone release seen in experimental models. 
LPS is known to exacerbate systemic inflammation when co-administered with 
cerulein in acute pancreatitis (Ding, Li et al. 2003) and infection of pancreatic 
necrosis leads to worse outcomes in clinical pancreatitis (Besselink, van 
Santvoort et al. 2009; Petrov, Shanbhag et al. 2010). This allows the hypothesis 
that pancreatic injury together with portal sepsis leads to extreme release of 
inflammatory mediators and fulminant systemic inflammation. It is possible 
that the gut microbiome contributes to the severity of the disease, as different 
bacterial species are likely to differ in their ability to translocate across the 
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injured intestinal mucosa and will stimulate hepatic cytokine release to 
differing degrees. 
8.4 Concluding Remarks 
The preceding chapters have described the early cellular events in the 
inflammatory response to pancreatic injury in acute pancreatitis, some of the 
feedback mechanisms and have highlighted the critical role of histones as 
mediators of pancreatic acinar cell death. By beginning to investigate the 
role of pancreatic blood flow and the porto-hepatic axis as gatekeepers of 
the pancreatic inflammatory syndrome, new treatment strategies can be 
developed as well as novel ways to monitor their success. 
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